<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?covid-19-tdm?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
    <journal-title-group>
      <journal-title>Scientific Reports</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2045-2322</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9636158</article-id>
    <article-id pub-id-type="pmid">36333579</article-id>
    <article-id pub-id-type="publisher-id">21988</article-id>
    <article-id pub-id-type="doi">10.1038/s41598-022-21988-6</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Environmental pathways affecting gene expression (E.PAGE) as an R package to predict gene–environment associations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Muralidharan</surname>
          <given-names>Sachin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Ali</surname>
          <given-names>Sarah</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Yang</surname>
          <given-names>Lilin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Badshah</surname>
          <given-names>Joshua</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zahir</surname>
          <given-names>Syeda Farah</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ali</surname>
          <given-names>Rubbiya A.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chandra</surname>
          <given-names>Janin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Frazer</surname>
          <given-names>Ian H.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Thomas</surname>
          <given-names>Ranjeny</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Mehdi</surname>
          <given-names>Ahmed M.</given-names>
        </name>
        <address>
          <email>a.mehdi@uq.edu.au</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>The University of Queensland Diamantina Institute, Translational Research Institute, </institution><institution>The University of Queensland, </institution></institution-wrap>37 Kent St, Woolloongabba, QLD 4102 Australia </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Centre for Microscopy and Microanalysis, </institution><institution>University of Queensland, </institution></institution-wrap>St. Lucia, QLD 4072 Australia </aff>
      <aff id="Aff3"><label>3</label>QCIF Facility for Advanced Bioinformatics, Queensland Cyber Infrastructure Foundation Ltd, Brisbane, QLD Australia </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>4</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>4</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>12</volume>
    <elocation-id>18710</elocation-id>
    <history>
      <date date-type="received">
        <day>5</day>
        <month>4</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>7</day>
        <month>10</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">The purpose of this study is to manually and semi-automatically curate a database and develop an R package that will act as a comprehensive resource to understand how biological processes are dysregulated due to interactions with environmental factors. The initial database search run on the Gene Expression Omnibus and the Molecular Signature Database retrieved a total of 90,018 articles. After title and abstract screening against pre-set criteria, a total of 237 datasets were selected and 522 gene modules were manually annotated. We then curated a database containing four environmental factors, <italic>cigarette smoking, diet, infections</italic> and <italic>toxic chemicals</italic>, along with a total of 25,789 genes that had an association with one or more of gene modules. The database and statistical analysis package was then tested with the differentially expressed genes obtained from the published literature related to type 1 diabetes, rheumatoid arthritis, small cell lung cancer, COVID-19, cobalt exposure and smoking. On testing, we uncovered statistically enriched biological processes, which revealed pathways associated with environmental factors and the genes. The curated database and enrichment tool are available as R packages at <ext-link ext-link-type="uri" xlink:href="https://github.com/AhmedMehdiLab/E.PATH">https://github.com/AhmedMehdiLab/E.PATH</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/AhmedMehdiLab/E.PAGE">https://github.com/AhmedMehdiLab/E.PAGE</ext-link> respectively.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Computational biology and bioinformatics</kwd>
      <kwd>Immunology</kwd>
      <kwd>Environmental biotechnology</kwd>
      <kwd>Genomics</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>PA Research Foundation</institution>
        </funding-source>
        <award-id>2020002553</award-id>
        <principal-award-recipient>
          <name>
            <surname>Mehdi</surname>
            <given-names>Ahmed M.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par2">Organisms are constantly being exposed to a wide range of environmental triggers that influence gene expression, resulting in several diseases. Environmental factors, such as drugs, toxic chemicals, smoke, temperature, dietary components and infections are considered modifiable causes of disease through their effects on biological processes, and in response, the expression of many genes is altered<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. It is estimated that environmental factors account for approximately 70% percent of all autoimmune diseases and 80% of all chronic diseases<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. These large proportions indicate that environmental exposures are an important contributor to disease, and there is ample evidence to support complex interrelationships between various environmental and genomic factors for disease causation<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Manipulation of environmental triggers and the host immune system during the clinical and preclinical stages of a disease will offer significant insight and guide early intervention for many disorders<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p>
    <p id="Par3">In the era of Big Data technologies, several genomic databases exist to explore differential expression of genes under various clinical conditions<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. However, to our knowledge there is currently no computational tool that can use information from existing large-scale databases to predict gene–environment relations. Therefore, in this study we formulated an integrated and comprehensive database that will provide insights of how environmental factors are associated to gene expression and disease, and leading to the identification of potential therapeutic strategies for the prevention and control of diseases attributable to both environmental and genetic factors.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <p id="Par4">We followed a two-step approach to conduct this study. First, we conducted a systematic review using a standard approach to identify all studies that used integrated datasets containing comprehensive information about environmental and genetic risk factors for various diseases. Second, we curated a database and developed a statistical analysis package to enable the user to understand the relationships between differentially expressed genes and select environmental factors.</p>
    <sec id="Sec3">
      <title>Step 1: Systematic review</title>
      <p id="Par5">The aim of this step was to identify the relevant published literature from where we could obtain existing data pertinent to gene expression changes in response to an environmental factor. In detail the systematic review was conducted as follows:</p>
    </sec>
    <sec id="Sec4">
      <title>Search strategy</title>
      <p id="Par6">We undertook a comprehensive literature and database search using PubMed, Gene expression omnibus (GEO), and Gene set enrichment analysis (GSEA) databases<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. All databases were searched from their inception until 16th October 2020. The reference lists of all the retrieved studies were examined to identify additional studies.</p>
      <p id="Par7">The search terms and their synonyms related to environmental factors and gene expression. The keywords used included medical subject headings (MeSH) terms, e.g., ("Diet"[MeSH Terms] OR diet [All Fields]) AND ("gene expression"[MeSH Terms] OR gene expression [All Fields]). Table <xref rid="Tab1" ref-type="table">1</xref> details the search strategy and date of searches for various databases.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Search strategies used for database searching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Search term</th><th align="left">Number of hits (total)</th><th align="left">Date of search hits</th></tr></thead><tbody><tr><td align="left">Cigarette smoking AND Gene expression</td><td align="left">324</td><td align="left">16/10/2020</td></tr><tr><td align="left">Diet AND Gene expression</td><td align="left">25,440</td><td align="left">16/10/2020</td></tr><tr><td align="left">Infection AND Gene expression [GEO Database]</td><td align="left">59,338</td><td align="left">16/10/2020</td></tr><tr><td align="left">C7 Immunologic gene sets [GSEA]</td><td align="left">4872</td><td align="left">16/10/2020</td></tr><tr><td align="left">Toxic chemical AND Gene expression</td><td align="left">44</td><td align="left">16/10/2020</td></tr></tbody></table></table-wrap></p>
      <sec id="Sec5">
        <title>Inclusion/exclusion criteria</title>
        <p id="Par8">Pre-set inclusion criterion for studies to be considered eligible were:<list list-type="bullet"><list-item><p id="Par9">Only articles written in English</p></list-item><list-item><p id="Par10">Participants of any age group and both genders.</p></list-item><list-item><p id="Par11">Since most of the experimental trials involving environmental factors were carried out in humans or mice, we included hits for Homo sapiens and Mus musculus.</p></list-item><list-item><p id="Par12">Four specific environmental factors were chosen, based on the previous published evidence for major contribution as an environmental factor affecting gene expression<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Specifically,<list list-type="simple"><list-item><label>o</label><p id="Par13">Cigarette smoking—Includes data related to the practice of tobacco smoking and inhalation of tobacco smoke.</p></list-item><list-item><label>p</label><p id="Par14">Diet—Includes data on the various types and quantities of food consumed by a person.</p></list-item><list-item><label>q</label><p id="Par15">Infections—Includes data on infections caused by pathogenic organisms such as viruses, bacteria, fungi, protozoa and parasites.</p></list-item><list-item><label>r</label><p id="Par16">Toxic chemicals—Includes data on substances such as metals or other chemical agents that are hazardous to human health if inhaled, ingested or absorbed.</p></list-item></list></p></list-item><list-item><p id="Par17">We included published data from datasets, series and platforms. Samples were excluded if they consisted of unpublished data. We did not limit the search specific for any disease.</p></list-item></list></p>
        <p id="Par18">We did not include any dataset relating to mRNA, protein, CDS or small non-coding RNAs like miRNA or siRNA.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Literature review method</title>
      <p id="Par19">Two reviewers SM and SA screened the abstracts and citations independently at the same date and time and using the same search parameters. We identified articles that met the inclusion criteria. After title and abstract screening, studies were selected for full-text review. After the full length article review, those studies that met the inclusion criteria were selected for data extraction<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p>
      <sec id="Sec7">
        <title>Harmonization step</title>
        <p id="Par20">Names of Differentially expressed genes were extracted from GEO and MSigDB C7 databases. Pre-set inclusion criteria were used to select studies to be included in the database. Overlapping studies from the two databases were considered and coded as one study into the spreadsheet. We have further illustrated the harmonization steps in Supplementary <xref rid="MOESM1" ref-type="media">SP4</xref> and Figure <xref rid="MOESM1" ref-type="media">S1</xref>.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Data extraction</title>
      <p id="Par21">Two reviewers SM and SA independently extracted data. The specific features extracted from each article were: (1) Differential gene expression data; (2) specific description of the type of data collected; (3) specific keywords related to the differentially expressed genes for each dataset, including disease, sample condition and pathways. These were manually searched in the abstract, demographics and result sections of each publication.</p>
      <sec id="Sec9">
        <title>Data coding</title>
        <p id="Par22">Data were extracted and coded in a spreadsheet to collate information from each study. The data were combined and any anomalies between reviewers were resolved by a third reviewer (LY).</p>
        <p id="Par23">Differential gene expression data were obtained from the results section as well as from the supplementary section of the article. The differentially expressed genesets were annotated based on the information provided in the results section of the article on specific biological processes and/or molecular function regulated. The differentially expressed genes were coded into a spreadsheet and each geneset was provided a unique geneset number. In another spreadsheet the same geneset numbers were provided with annotations extracted from the article and a short description was given to describe the geneset module.</p>
        <p id="Par24">To remove potential bias of manual annotations, E.PAGE also provides functionality to anno<xref rid="MOESM1" ref-type="media">SP1</xref>tate each geneset using GO, KEGG and MeSH annotations<sup><xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref></sup> and users have an option to use either of methods or all. Further description on manual curation is provided in supplementary .</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Quality and data validity assessment</title>
      <p id="Par25">The methodological quality was checked before including the data, using the Q-Genie tool<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. We recorded whether the study used a standard microarray procedure and descriptions of the sample data, causes of up- and downregulation of genes and any other specific changes in the gene expression.</p>
    </sec>
    <sec id="Sec11">
      <title>Step 2: Software generation</title>
      <p id="Par26">The statistical analysis package E.PAGE (Environmental Pathways Affecting Gene Expression) (<ext-link ext-link-type="uri" xlink:href="https://github.com/AhmedMehdiLab/E.PAGE">https://github.com/AhmedMehdiLab/E.PAGE</ext-link>) was written in R version 4.0.3<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> and developed using RStudio<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Using publicly available packages tidyverse<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> , Seurat<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> as dependencies, the package performs enrichment analysis as previously described by Mehdi and colleagues<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.</p>
      <p id="Par27">Mathematically, we represent the collection of annotated modules as <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{M}=\{\mathrm{m}}_{1},{\mathrm{m}}_{2},\ldots{\mathrm{m}}_{\mathrm{n}}\}$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="normal">m</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:msub><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq1.gif"/></alternatives></inline-formula> and the universal set of genes (background) as <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{U}=\{{\mathrm{g}}_{1 } ,{\mathrm{g}}_{2 },..{\mathrm{g}}_{\mathrm{w}}\}\mathrm{ with}\, \mathrm{total}\, \mathrm{of}\, \mathrm{w}(\mathrm{U})$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi mathvariant="normal">U</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:msub><mml:mi mathvariant="normal">g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="normal">g</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:msub><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">w</mml:mi></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:mrow><mml:mi mathvariant="normal">with</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">total</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">of</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">w</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">U</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq2.gif"/></alternatives></inline-formula> genes. For each query list of genes <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{g}\subseteq \mathrm{U containing n}(\mathrm{g})\mathrm{ genes}\,\mathrm{ in}\, \mathrm{query}\, \mathrm{list},$$\end{document}</tex-math><mml:math id="M6"><mml:mrow><mml:mi mathvariant="normal">g</mml:mi><mml:mo>⊆</mml:mo><mml:mrow><mml:mi mathvariant="normal">U</mml:mi><mml:mi mathvariant="normal">containing</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi mathvariant="normal">genes</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">in</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">query</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">list</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq3.gif"/></alternatives></inline-formula> we perform statistical enrichment of each module <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{m}$$\end{document}</tex-math><mml:math id="M8"><mml:mi mathvariant="normal">m</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq4.gif"/></alternatives></inline-formula> where <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{m }\in \{{\mathrm{m}}_{1},{\mathrm{m}}_{2},..{\mathrm{m}}_{\mathrm{N}}\}$$\end{document}</tex-math><mml:math id="M10"><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mo>∈</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:msub><mml:mi mathvariant="normal">m</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="normal">m</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:msub><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq5.gif"/></alternatives></inline-formula> with <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{N}}_{\mathrm{m}}^{\mathrm{tot}}$$\end{document}</tex-math><mml:math id="M12"><mml:msubsup><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mi mathvariant="normal">tot</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq6.gif"/></alternatives></inline-formula> genes associated with <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{m}$$\end{document}</tex-math><mml:math id="M14"><mml:mi mathvariant="normal">m</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq7.gif"/></alternatives></inline-formula>. We compared the number of genes <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{N}}_{\mathrm{m}}^{\mathrm{g}}$$\end{document}</tex-math><mml:math id="M16"><mml:msubsup><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq8.gif"/></alternatives></inline-formula> that had a specific annotation for gene module <inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{m}}$$\end{document}</tex-math><mml:math id="M18"><mml:mtext>m</mml:mtext></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq9.gif"/></alternatives></inline-formula> against those that did not. A hypergeometric distribution was used to determine a probability (p-value) that <inline-formula id="IEq10"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{N}}_{\mathrm{m}}^{\mathrm{g}}$$\end{document}</tex-math><mml:math id="M20"><mml:msubsup><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq10.gif"/></alternatives></inline-formula> or more belong to the module <inline-formula id="IEq11"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{m}}$$\end{document}</tex-math><mml:math id="M22"><mml:mtext>m</mml:mtext></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq11.gif"/></alternatives></inline-formula> can be calculated using fisher exact test<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. The p-value was corrected using false discovery rate (FDR) for multiple hypothesis testing using the Benjamini and Hochberg correction method<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> to determine the adjusted p-value (<inline-formula id="IEq12"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq12.gif"/></alternatives></inline-formula>). The results are filtered based on the <inline-formula id="IEq13"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq13.gif"/></alternatives></inline-formula> are displayed to the user. Fold enrichment was calculated by taking the ratio of a set of genes containing a specific gene modules, and the total set of genes was obtained by taking the union of all the collected gene modules<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> as follows; <inline-formula id="IEq14"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$F.E = \frac{{N_{{gm}} /\user2{n}\left( \user2{g} \right)}}{{\user2{N}_{\user2{m}}^{{\user2{tot}}} /\user2{w}\left( \user2{U} \right)}}$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mi>F</mml:mi><mml:mo>.</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant="italic">gm</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">g</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant="bold-italic">N</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">tot</mml:mi></mml:mrow></mml:msubsup><mml:mo stretchy="false">/</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">w</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">U</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq14.gif"/></alternatives></inline-formula>. The adjusted fold enrichment was measured as a ratio of the fold enrichment value to the negative log of <inline-formula id="IEq15"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq15.gif"/></alternatives></inline-formula>. An odds ratio then was measured to determine the probability of finding the set of enriched genes specific to an gene module<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. We determined the percentage of interactions for four environmental variables (<inline-formula id="IEq16"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${I}_{\widetilde{m}})$$\end{document}</tex-math><mml:math id="M32"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mover accent="true"><mml:mi>m</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover></mml:msub><mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq16.gif"/></alternatives></inline-formula> where <inline-formula id="IEq17"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widetilde{m}=\{\mathrm{cigarette}\,\mathrm{smoking }, \mathrm{diet}, \mathrm{infections },\mathrm{toxic}\, \mathrm{chemicals}\}$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mover accent="true"><mml:mi>m</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:mi mathvariant="normal">cigarette</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">smoking</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">diet</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">infections</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">toxic</mml:mi><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">chemicals</mml:mi><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq17.gif"/></alternatives></inline-formula>, <inline-formula id="IEq18"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widetilde{m}\subseteq {\varvec{M}}$$\end{document}</tex-math><mml:math id="M36"><mml:mrow><mml:mover accent="true"><mml:mi>m</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover><mml:mo>⊆</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">M</mml:mi></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq18.gif"/></alternatives></inline-formula><bold>,</bold> as follows; <inline-formula id="IEq19"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{I}}_{\widetilde{\mathrm{m}}}=\frac{{\mathrm{N}}_{\widetilde{\mathrm{m}}}^{\mathrm{g}}}{{\mathrm{N}}_{\widetilde{\mathrm{m}}}^{\mathrm{tot}}}\times 100$$\end{document}</tex-math><mml:math id="M38"><mml:mrow><mml:msub><mml:mi mathvariant="normal">I</mml:mi><mml:mover accent="true"><mml:mi mathvariant="normal">m</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msubsup><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="normal">m</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover></mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:msubsup><mml:msubsup><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="normal">m</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover></mml:mrow><mml:mi mathvariant="normal">tot</mml:mi></mml:msubsup></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq19.gif"/></alternatives></inline-formula>. We have provided examples of running E.PAGE in supplementary <xref rid="MOESM1" ref-type="media">SP2</xref>.</p>
    </sec>
    <sec id="Sec12">
      <title>Step 3: Case studies</title>
      <p id="Par28">We used six case studies to test our enrichment tool, these studies were not used in database curation. Case study 1 involves gene expression data in peripheral blood mononuclear cells (PBMC) in children with type 1 diabetes<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Gene expression changes were identified using microarray analysis from 43 patients with new onset T1D compared with 24 healthy controls. The gene expression data set in case study 2 is taken from the GEO database (microarray datasets; GSE12021, GSE55457, GSE55584 and GSE55235) that includes samples from 45 patients with rheumatoid arthritis, compared with 29 healthy control samples<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Case study 3 includes gene expression data from 23 small cell lung cancer samples and 42 healthy lung tissues<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. The gene expression data from the case study 4 was taken from cobalt-exposed rat liver derived cells<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. The final two case studies used differentially expressed genes extracted from single-cell expression data. Case study 5 was based on single-cell RNAseq data from COVID-19 patients, comparing severe and healthy cases in peripheral immune environments<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, while case study 6 was based on a single-cell RNAseq-based atlas of epithelial cell-specific responses to smoking<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. For single-cell RNA seq data, E.PAGE used a Seurat object (with clustering performed) as an input and performs differential expression analyses between the clusters to uncover lists of genes to compute related enriched gene modules.</p>
    </sec>
  </sec>
  <sec id="Sec13">
    <title>Results</title>
    <sec id="Sec14">
      <title>Systematic review and E.PAGE structure</title>
      <p id="Par29">The initial electronic search of GEO and MSigDB database identified a total of 90,018 studies (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Title and abstract screening of retrieved studies resulted in a total of 3547 studies which had potential data related to environmental factors. After full text examination of 3547 studies, 3008 studies were excluded since they did not provide any differential gene expression data associated with any of the four environmental factors. A total of 237 datasets were obtained from 186 studies and the gene expression data were retrieved and collated to form a database. Figure <xref rid="Fig1" ref-type="fig">1</xref> illustrates a flow chart of all the steps taken to obtain the data that satisfy the required parameters. The overall structure of E.PAGE is shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. After literature screening, a database of 237 datasets was developed by linking each dataset with published lists of differentially expressed genes and the gene modules. Specifically, the text of these 186 publications and associated datasets were manually screened to develop gene modules representing the type of experiment, experimental conditions or disease type, experimental factors, demographics of subjects, and published pathways as previously described by Mehdi and colleagues<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. The final database consisting of 237 datasets is obtained through GEO and MSigDB databases and includes 18,015 genes for <italic>diet</italic>, 13,259 genes for <italic>infections</italic>, 3841 genes for <italic>cigarette smoking</italic> and 644 genes for <italic>toxic chemicals</italic>.<fig id="Fig1"><label>Figure 1</label><caption><p>PRISMA flow chart representing the various stages of screening involved in the systematic review process.</p></caption><graphic xlink:href="41598_2022_21988_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>Flow chart representing the various parameters and their utilities provided on database query.</p></caption><graphic xlink:href="41598_2022_21988_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec15">
      <title>Querying E.PAGE</title>
      <p id="Par30">An R package was developed to enable statistical enrichment and gene modules associated with datasets/genes of interest to a user. The package produces various data tables as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref> and a user can search genes of interest for their statistical enrichment. To test the utility of the statistical analysis package, we performed six case studies as described hereafter.</p>
    </sec>
    <sec id="Sec16">
      <title>Case studies 1 and 2: Immune response activation in type-1 diabetes and rheumatoid arthritis</title>
      <p id="Par31">We first tested whether query signatures associated with T1D and RA could recover common pathways associated with these autoimmune disease. We used 291 DE genes uncovered from 43 patients with new-onset T1D as compared to 24 healthy controls<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> (Table <xref rid="Tab2" ref-type="table">2</xref>) and 229 DE genes from 45 samples from patients with RA, compared with 29 healthy control samples<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> (Table <xref rid="Tab3" ref-type="table">3</xref>). The statistical enrichment using E.PAGE identified that the genes in both datasets are involved in <italic>Immune response</italic>. Other significant gene modules that were common to both diseases include <italic>Interferons</italic>, <italic>IL-12</italic> and <italic>Transcription regulation</italic>. These processes are all well known to be involved in RA and T1D<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. <italic>Insulin resistance</italic> and <italic>Xenobiotic metabolism,</italic> which are both believed to be associated with T1D, were uncovered using E.PAGE and validate the utility of the platform (Table <xref rid="Tab2" ref-type="table">2</xref>). Similarly, for RA, many smoking related gene modules such as Smoking history and Pack years (<italic>Smoking Status: Current, Never</italic>, <italic>Pack-years: (10–20)</italic>, <italic>Pack-years: (20–30; Healthy smoker)</italic>, <italic>(Above 40; Smoker with COPD)</italic>), were uncovered indicating an important risk factor for this disease (Table <xref rid="Tab3" ref-type="table">3</xref>). For both T1D and RA, a large number of gene modules related to infections, both viral and bacterial (<italic>Lyme disease</italic>, <italic>Borrelia burgdorferi</italic>, <italic>HBV Infection</italic>, <italic>Viral response</italic>, <italic>Bacterial infection</italic>, <italic>Zika virus</italic>, <italic>Influenza A Infection</italic>, <italic>HIV infection</italic>, <italic>Echovirus-30</italic>, <italic>Rhinovirus infection</italic>), were significantly associated with disease, indicating that similar responses are occurring in patients suffering from these chronic autoimmune diseases as in responses to infections.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Collation of results obtained on query of E.PAGE with genes differentially expressed in Type 1 Diabetes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene modules</th><th align="left">Number of modules</th><th align="left">Number of DE genes</th><th align="left"><inline-formula id="IEq20"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M40"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq20.gif"/></alternatives></inline-formula></th><th align="left">Fold enrichment</th></tr></thead><tbody><tr><td align="left">Dyslipemia</td><td align="left">1</td><td align="left">13</td><td align="left">1.46E−08</td><td char="." align="char">12.88</td></tr><tr><td align="left">Olive oil induced gene expression</td><td align="left">3</td><td align="left">15</td><td align="left">7.52E−08</td><td char="." align="char">8.58</td></tr><tr><td align="left">Diet intake: Olive oil</td><td align="left">2</td><td align="left">14</td><td align="left">1.14E−07</td><td char="." align="char">8.96</td></tr><tr><td align="left">Inflammation</td><td align="left">31</td><td align="left">82</td><td align="left">6.87E−07</td><td char="." align="char">1.85</td></tr><tr><td align="left">Infection type: Acute</td><td align="left">58</td><td align="left">112</td><td align="left">7.46E−07</td><td char="." align="char">1.61</td></tr><tr><td align="left">Transcription regulation</td><td align="left">11</td><td align="left">33</td><td align="left">8.00E−07</td><td char="." align="char">3.09</td></tr><tr><td align="left">Interferons</td><td align="left">15</td><td align="left">53</td><td align="left">1.66E−06</td><td char="." align="char">2.22</td></tr><tr><td align="left">IL-12</td><td align="left">4</td><td align="left">37</td><td align="left">5.02E−06</td><td char="." align="char">2.60</td></tr><tr><td align="left">Th1-mediated response</td><td align="left">4</td><td align="left">37</td><td align="left">5.02E−06</td><td char="." align="char">2.60</td></tr><tr><td align="left">Parasite killing</td><td align="left">4</td><td align="left">37</td><td align="left">5.02E−06</td><td char="." align="char">2.60</td></tr><tr><td align="left">Non-smoker vs Smoker</td><td align="left">16</td><td align="left">46</td><td align="left">3.21E−05</td><td char="." align="char">2.13</td></tr><tr><td align="left">Type 2 Diabetes</td><td align="left">5</td><td align="left">16</td><td align="left">5.99E−05</td><td char="." align="char">4.24</td></tr><tr><td align="left">Early Disseminated</td><td align="left">1</td><td align="left">12</td><td align="left">1.11E−04</td><td char="." align="char">5.35</td></tr><tr><td align="left">Immune response</td><td align="left">46</td><td align="left">83</td><td align="left">1.20E−04</td><td char="." align="char">1.59</td></tr><tr><td align="left">Cigarette smoking</td><td align="left">36</td><td align="left">61</td><td align="left">1.57E−04</td><td char="." align="char">1.77</td></tr><tr><td align="left">Monocytes</td><td align="left">10</td><td align="left">34</td><td align="left">2.21E−04</td><td char="." align="char">2.26</td></tr><tr><td align="left">Airway epithelium</td><td align="left">26</td><td align="left">58</td><td align="left">2.21E−04</td><td char="." align="char">1.78</td></tr><tr><td align="left">Reactive oxygen species</td><td align="left">12</td><td align="left">58</td><td align="left">2.69E−04</td><td char="." align="char">1.76</td></tr><tr><td align="left">Mycobacterium tuberculosis</td><td align="left">3</td><td align="left">14</td><td align="left">3.67E−04</td><td char="." align="char">3.97</td></tr><tr><td align="left">Smoking Status: Current, Never</td><td align="left">23</td><td align="left">36</td><td align="left">6.22E−04</td><td char="." align="char">2.08</td></tr><tr><td align="left">Chronic obstructive pulmonary disease</td><td align="left">16</td><td align="left">30</td><td align="left">6.36E−04</td><td char="." align="char">2.26</td></tr><tr><td align="left">Polymorphonuclear leukocytes</td><td align="left">10</td><td align="left">55</td><td align="left">1.08E−03</td><td char="." align="char">1.70</td></tr><tr><td align="left">Anaplasma phagocytophilum</td><td align="left">10</td><td align="left">55</td><td align="left">1.08E−03</td><td char="." align="char">1.70</td></tr><tr><td align="left">Granulocytic anaplasmosis</td><td align="left">10</td><td align="left">55</td><td align="left">1.08E−03</td><td char="." align="char">1.70</td></tr><tr><td align="left">Metabolism</td><td align="left">7</td><td align="left">35</td><td align="left">1.27E−03</td><td char="." align="char">2.01</td></tr><tr><td align="left">Epithelial gene expression</td><td align="left">16</td><td align="left">36</td><td align="left">1.27E−03</td><td char="." align="char">1.98</td></tr><tr><td align="left">Lyme disease</td><td align="left">2</td><td align="left">15</td><td align="left">1.27E−03</td><td char="." align="char">3.24</td></tr><tr><td align="left">Borrelia burgdorferi</td><td align="left">2</td><td align="left">15</td><td align="left">1.27E−03</td><td char="." align="char">3.24</td></tr><tr><td align="left">PBMCs</td><td align="left">22</td><td align="left">58</td><td align="left">1.27E−03</td><td char="." align="char">1.65</td></tr><tr><td align="left">DE genes expressed in Obese, Lean</td><td align="left">3</td><td align="left">94</td><td align="left">2.28E−03</td><td char="." align="char">1.39</td></tr><tr><td align="left">Obese vs Lean</td><td align="left">2</td><td align="left">94</td><td align="left">2.28E−03</td><td char="." align="char">1.39</td></tr><tr><td align="left">Apoptosis</td><td align="left">34</td><td align="left">85</td><td align="left">4.29E−03</td><td char="." align="char">1.40</td></tr><tr><td align="left">Protein catabolism</td><td align="left">2</td><td align="left">10</td><td align="left">5.26E−03</td><td char="." align="char">3.63</td></tr><tr><td align="left">Plasmodium falciparum</td><td align="left">1</td><td align="left">14</td><td align="left">5.26E−03</td><td char="." align="char">2.83</td></tr><tr><td align="left">Malaria</td><td align="left">1</td><td align="left">14</td><td align="left">5.26E−03</td><td char="." align="char">2.83</td></tr><tr><td align="left">Blood monocytes</td><td align="left">1</td><td align="left">14</td><td align="left">5.26E−03</td><td char="." align="char">2.83</td></tr><tr><td align="left">Hepatocellular carcinoma</td><td align="left">1</td><td align="left">29</td><td align="left">5.26E−03</td><td char="." align="char">1.95</td></tr><tr><td align="left">HBV Infection</td><td align="left">1</td><td align="left">29</td><td align="left">5.26E−03</td><td char="." align="char">1.95</td></tr><tr><td align="left">Infection type: Chronic</td><td align="left">29</td><td align="left">66</td><td align="left">5.60E−03</td><td char="." align="char">1.47</td></tr><tr><td align="left">Infection induced gene expression</td><td align="left">110</td><td align="left">148</td><td align="left">6.10E−03</td><td char="." align="char">1.21</td></tr><tr><td align="left">Pack-years: (10–20)</td><td align="left">5</td><td align="left">14</td><td align="left">6.83E−03</td><td char="." align="char">2.74</td></tr><tr><td align="left">Diet intake: Dietary energy restriction</td><td align="left">3</td><td align="left">25</td><td align="left">7.21E−03</td><td char="." align="char">2.01</td></tr><tr><td align="left">DE genes expressed in Obese</td><td align="left">15</td><td align="left">33</td><td align="left">7.27E−03</td><td char="." align="char">1.80</td></tr><tr><td align="left">Idiopathic pulmonary fibrosis</td><td align="left">1</td><td align="left">13</td><td align="left">7.33E−03</td><td char="." align="char">2.82</td></tr><tr><td align="left">Cytokines</td><td align="left">4</td><td align="left">12</td><td align="left">1.00E−02</td><td char="." align="char">2.83</td></tr><tr><td align="left">Lung cancer</td><td align="left">8</td><td align="left">23</td><td align="left">1.00E−02</td><td char="." align="char">2.01</td></tr><tr><td align="left">Viral response</td><td align="left">9</td><td align="left">25</td><td align="left">1.00E−02</td><td char="." align="char">1.94</td></tr><tr><td align="left">Mannose metabolism</td><td align="left">1</td><td align="left">88</td><td align="left">1.00E−02</td><td char="." align="char">1.34</td></tr><tr><td align="left">Insulin resistance</td><td align="left">7</td><td align="left">89</td><td align="left">1.00E−02</td><td char="." align="char">1.33</td></tr><tr><td align="left">Adipose tissue gene expression</td><td align="left">3</td><td align="left">88</td><td align="left">1.05E−02</td><td char="." align="char">1.33</td></tr><tr><td align="left">DE genes expressed in Healthy</td><td align="left">11</td><td align="left">31</td><td align="left">1.09E−02</td><td char="." align="char">1.77</td></tr><tr><td align="left">Before vs After diet intake</td><td align="left">7</td><td align="left">19</td><td align="left">1.23E−02</td><td char="." align="char">2.13</td></tr><tr><td align="left">Blood immune cells</td><td align="left">20</td><td align="left">37</td><td align="left">1.23E−02</td><td char="." align="char">1.65</td></tr><tr><td align="left">Influenza A Infection</td><td align="left">20</td><td align="left">37</td><td align="left">1.23E−02</td><td char="." align="char">1.65</td></tr><tr><td align="left">E. coli infection</td><td align="left">20</td><td align="left">37</td><td align="left">1.23E−02</td><td char="." align="char">1.65</td></tr><tr><td align="left">Staphylococcus aureus infection</td><td align="left">20</td><td align="left">37</td><td align="left">1.23E−02</td><td char="." align="char">1.65</td></tr><tr><td align="left">Streptococcus pneumoniae infection</td><td align="left">20</td><td align="left">37</td><td align="left">1.23E−02</td><td char="." align="char">1.65</td></tr><tr><td align="left">T effector cells</td><td align="left">2</td><td align="left">11</td><td align="left">1.39E−02</td><td char="." align="char">2.82</td></tr><tr><td align="left">Helminth infection</td><td align="left">2</td><td align="left">11</td><td align="left">1.39E−02</td><td char="." align="char">2.82</td></tr><tr><td align="left">Macrophages</td><td align="left">17</td><td align="left">49</td><td align="left">1.53E−02</td><td char="." align="char">1.50</td></tr><tr><td align="left">Lipid metabolism</td><td align="left">9</td><td align="left">33</td><td align="left">1.58E−02</td><td char="." align="char">1.68</td></tr><tr><td align="left">Infection induced gene expression in mice</td><td align="left">18</td><td align="left">39</td><td align="left">1.65E−02</td><td char="." align="char">1.58</td></tr><tr><td align="left">Dendritic cells</td><td align="left">20</td><td align="left">73</td><td align="left">1.65E−02</td><td char="." align="char">1.35</td></tr><tr><td align="left">Vascularization</td><td align="left">1</td><td align="left">13</td><td align="left">1.77E−02</td><td char="." align="char">2.42</td></tr><tr><td align="left">Energy restriction associated gene expression</td><td align="left">2</td><td align="left">22</td><td align="left">1.77E−02</td><td char="." align="char">1.90</td></tr><tr><td align="left">Oxidative stress</td><td align="left">11</td><td align="left">24</td><td align="left">1.89E−02</td><td char="." align="char">1.82</td></tr><tr><td align="left">Hematopoiesis</td><td align="left">2</td><td align="left">13</td><td align="left">1.95E−02</td><td char="." align="char">2.38</td></tr><tr><td align="left">Vesicular traffic</td><td align="left">1</td><td align="left">12</td><td align="left">2.10E−02</td><td char="." align="char">2.43</td></tr><tr><td align="left">DE genes expressed in Insulin sensitive individuals</td><td align="left">1</td><td align="left">12</td><td align="left">2.10E−02</td><td char="." align="char">2.43</td></tr><tr><td align="left">Lipid induced gene expression</td><td align="left">1</td><td align="left">15</td><td align="left">2.22E−02</td><td char="." align="char">2.15</td></tr><tr><td align="left">Xenobiotic metabolism</td><td align="left">4</td><td align="left">13</td><td align="left">2.66E−02</td><td char="." align="char">2.26</td></tr><tr><td align="left">Bacterial infection</td><td align="left">4</td><td align="left">13</td><td align="left">2.82E−02</td><td char="." align="char">2.24</td></tr><tr><td align="left">Protein Metabolism</td><td align="left">2</td><td align="left">12</td><td align="left">3.00E−02</td><td char="." align="char">2.31</td></tr><tr><td align="left">Skeletal muscle gene expression</td><td align="left">2</td><td align="left">12</td><td align="left">3.03E−02</td><td char="." align="char">2.30</td></tr><tr><td align="left">Maternal cigarette smoking</td><td align="left">2</td><td align="left">13</td><td align="left">3.03E−02</td><td char="." align="char">2.20</td></tr><tr><td align="left">Mosquito-borne pathogen</td><td align="left">7</td><td align="left">21</td><td align="left">3.58E−02</td><td char="." align="char">1.77</td></tr><tr><td align="left">Signal Transduction</td><td align="left">7</td><td align="left">15</td><td align="left">3.62E−02</td><td char="." align="char">2.01</td></tr><tr><td align="left">Zika virus</td><td align="left">8</td><td align="left">21</td><td align="left">4.12E−02</td><td char="." align="char">1.75</td></tr><tr><td align="left">Pack-years: (20–30; Healthy smoker), (Above 40; Smoker with COPD)</td><td align="left">4</td><td align="left">12</td><td align="left">4.50E−02</td><td char="." align="char">2.15</td></tr></tbody></table></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Collation of results obtained on query of E.PAGE with genes differentially expressed in Rheumatoid Arthritis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene modules</th><th align="left">Number of modules</th><th align="left">Number of DE genes</th><th align="left"><inline-formula id="IEq21"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq21.gif"/></alternatives></inline-formula></th><th align="left">Fold enrichment</th></tr></thead><tbody><tr><td align="left">Infection type: Acute</td><td align="left">58</td><td align="left">131</td><td align="left">8.49E−34</td><td char="." align="char">2.63</td></tr><tr><td align="left">Immune response</td><td align="left">46</td><td align="left">107</td><td align="left">1.03E−27</td><td char="." align="char">2.87</td></tr><tr><td align="left">Infection induced gene expression</td><td align="left">110</td><td align="left">159</td><td align="left">1.03E−27</td><td char="." align="char">1.82</td></tr><tr><td align="left">Inflammation</td><td align="left">31</td><td align="left">91</td><td align="left">5.26E−22</td><td char="." align="char">2.88</td></tr><tr><td align="left">PBMCs</td><td align="left">22</td><td align="left">78</td><td align="left">6.89E−20</td><td char="." align="char">3.10</td></tr><tr><td align="left">Transcription regulation</td><td align="left">11</td><td align="left">44</td><td align="left">1.16E−19</td><td char="." align="char">5.77</td></tr><tr><td align="left">Interferons</td><td align="left">15</td><td align="left">63</td><td align="left">3.98E−19</td><td char="." align="char">3.70</td></tr><tr><td align="left">Central nervous system</td><td align="left">4</td><td align="left">27</td><td align="left">4.96E−18</td><td char="." align="char">10.49</td></tr><tr><td align="left">Infection type: Chronic</td><td align="left">29</td><td align="left">85</td><td align="left">5.19E−18</td><td char="." align="char">2.65</td></tr><tr><td align="left">Astrocytes</td><td align="left">2</td><td align="left">17</td><td align="left">1.94E−17</td><td char="." align="char">24.50</td></tr><tr><td align="left">Plasmodium falciparum</td><td align="left">1</td><td align="left">29</td><td align="left">9.43E−17</td><td char="." align="char">8.21</td></tr><tr><td align="left">Malaria</td><td align="left">1</td><td align="left">29</td><td align="left">9.43E−17</td><td char="." align="char">8.21</td></tr><tr><td align="left">Blood monocytes</td><td align="left">1</td><td align="left">29</td><td align="left">9.43E−17</td><td char="." align="char">8.21</td></tr><tr><td align="left">Dendritic cells</td><td align="left">20</td><td align="left">91</td><td align="left">1.85E−16</td><td char="." align="char">2.36</td></tr><tr><td align="left">Mycobacterium tuberculosis</td><td align="left">3</td><td align="left">25</td><td align="left">2.53E−16</td><td char="." align="char">9.93</td></tr><tr><td align="left">Infection induced gene expression in mice</td><td align="left">18</td><td align="left">59</td><td align="left">4.97E−16</td><td char="." align="char">3.35</td></tr><tr><td align="left">Pro-inflammatory response</td><td align="left">1</td><td align="left">15</td><td align="left">1.72E−15</td><td char="." align="char">24.29</td></tr><tr><td align="left">Chemokines</td><td align="left">2</td><td align="left">17</td><td align="left">3.11E−15</td><td char="." align="char">17.76</td></tr><tr><td align="left">Viral response</td><td align="left">9</td><td align="left">41</td><td align="left">9.93E−15</td><td char="." align="char">4.46</td></tr><tr><td align="left">Monocytes</td><td align="left">10</td><td align="left">43</td><td align="left">7.69E−14</td><td char="." align="char">4.00</td></tr><tr><td align="left">Olive oil induced gene expression</td><td align="left">3</td><td align="left">17</td><td align="left">2.43E−13</td><td char="." align="char">13.61</td></tr><tr><td align="left">Bacterial infection</td><td align="left">4</td><td align="left">27</td><td align="left">2.79E−13</td><td char="." align="char">6.51</td></tr><tr><td align="left">Dyslipemia</td><td align="left">1</td><td align="left">14</td><td align="left">3.35E−13</td><td char="." align="char">19.40</td></tr><tr><td align="left">Bone marrow monocytes</td><td align="left">1</td><td align="left">16</td><td align="left">3.35E−13</td><td char="." align="char">14.78</td></tr><tr><td align="left">Myelodysplastic syndromes</td><td align="left">1</td><td align="left">16</td><td align="left">3.35E−13</td><td char="." align="char">14.78</td></tr><tr><td align="left">Hematopoietic stem cell disease</td><td align="left">1</td><td align="left">16</td><td align="left">3.35E−13</td><td char="." align="char">14.78</td></tr><tr><td align="left">Lyme disease</td><td align="left">2</td><td align="left">24</td><td align="left">7.14E−13</td><td char="." align="char">7.25</td></tr><tr><td align="left">Borrelia burgdorferi</td><td align="left">2</td><td align="left">24</td><td align="left">7.14E−13</td><td char="." align="char">7.25</td></tr><tr><td align="left">IL-12</td><td align="left">4</td><td align="left">39</td><td align="left">4.66E−12</td><td char="." align="char">3.84</td></tr><tr><td align="left">Th1-mediated response</td><td align="left">4</td><td align="left">39</td><td align="left">4.66E−12</td><td char="." align="char">3.84</td></tr><tr><td align="left">Parasite killing</td><td align="left">4</td><td align="left">39</td><td align="left">4.66E−12</td><td char="." align="char">3.84</td></tr><tr><td align="left">Diet intake: Olive oil</td><td align="left">2</td><td align="left">15</td><td align="left">7.67E−12</td><td char="." align="char">13.43</td></tr><tr><td align="left">Airway epithelium</td><td align="left">26</td><td align="left">60</td><td align="left">2.08E−11</td><td char="." align="char">2.57</td></tr><tr><td align="left">DE genes expressed in Obese</td><td align="left">15</td><td align="left">43</td><td align="left">3.55E−11</td><td char="." align="char">3.28</td></tr><tr><td align="left">Blood immune cells</td><td align="left">20</td><td align="left">48</td><td align="left">3.55E−11</td><td char="." align="char">2.99</td></tr><tr><td align="left">Influenza A Infection</td><td align="left">20</td><td align="left">48</td><td align="left">3.55E−11</td><td char="." align="char">2.99</td></tr><tr><td align="left">E. coli infection</td><td align="left">20</td><td align="left">48</td><td align="left">3.55E−11</td><td char="." align="char">2.99</td></tr><tr><td align="left">Staphylococcus aureus infection</td><td align="left">20</td><td align="left">48</td><td align="left">3.55E−11</td><td char="." align="char">2.99</td></tr><tr><td align="left">Streptococcus pneumoniae infection</td><td align="left">20</td><td align="left">48</td><td align="left">3.55E−11</td><td char="." align="char">2.99</td></tr><tr><td align="left">Mosquito-borne pathogen</td><td align="left">7</td><td align="left">34</td><td align="left">4.44E−11</td><td char="." align="char">4.02</td></tr><tr><td align="left">Zika virus</td><td align="left">8</td><td align="left">34</td><td align="left">6.48E−11</td><td char="." align="char">3.96</td></tr><tr><td align="left">Tissue remodeling</td><td align="left">1</td><td align="left">10</td><td align="left">1.04E−09</td><td char="." align="char">19.74</td></tr><tr><td align="left">Immunoregulation</td><td align="left">1</td><td align="left">10</td><td align="left">1.04E−09</td><td char="." align="char">19.74</td></tr><tr><td align="left">Hepatocellular carcinoma</td><td align="left">1</td><td align="left">36</td><td align="left">1.13E−09</td><td char="." align="char">3.38</td></tr><tr><td align="left">HBV Infection</td><td align="left">1</td><td align="left">36</td><td align="left">1.13E−09</td><td char="." align="char">3.38</td></tr><tr><td align="left">Chronic obstructive pulmonary disease</td><td align="left">16</td><td align="left">33</td><td align="left">3.61E−09</td><td char="." align="char">3.48</td></tr><tr><td align="left">Lipid metabolism</td><td align="left">9</td><td align="left">41</td><td align="left">3.98E−09</td><td char="." align="char">2.91</td></tr><tr><td align="left">Cigarette smoking</td><td align="left">36</td><td align="left">57</td><td align="left">4.61E−09</td><td char="." align="char">2.31</td></tr><tr><td align="left">Macrophages</td><td align="left">17</td><td align="left">54</td><td align="left">1.51E−08</td><td char="." align="char">2.31</td></tr><tr><td align="left">HIV infection</td><td align="left">9</td><td align="left">30</td><td align="left">1.59E−08</td><td char="." align="char">3.54</td></tr><tr><td align="left">Non-smoker vs Smoker</td><td align="left">16</td><td align="left">42</td><td align="left">1.60E−08</td><td char="." align="char">2.72</td></tr><tr><td align="left">Metabolism</td><td align="left">7</td><td align="left">37</td><td align="left">1.82E−08</td><td char="." align="char">2.97</td></tr><tr><td align="left">Zika virus associated pDCs response</td><td align="left">1</td><td align="left">15</td><td align="left">3.13E−08</td><td char="." align="char">7.21</td></tr><tr><td align="left">Early Disseminated</td><td align="left">1</td><td align="left">13</td><td align="left">8.80E−08</td><td char="." align="char">8.11</td></tr><tr><td align="left">Apoptosis</td><td align="left">34</td><td align="left">78</td><td align="left">9.83E−08</td><td char="." align="char">1.80</td></tr><tr><td align="left">Type 2 Diabetes</td><td align="left">5</td><td align="left">16</td><td align="left">1.40E−07</td><td char="." align="char">5.93</td></tr><tr><td align="left">Reactive oxygen species</td><td align="left">12</td><td align="left">52</td><td align="left">1.44E−07</td><td char="." align="char">2.21</td></tr><tr><td align="left">Fusobacterium nucleatum</td><td align="left">3</td><td align="left">10</td><td align="left">1.58E−07</td><td char="." align="char">11.53</td></tr><tr><td align="left">Oral pathogen</td><td align="left">3</td><td align="left">10</td><td align="left">1.58E−07</td><td char="." align="char">11.53</td></tr><tr><td align="left">Diet intake: Low calorie diet</td><td align="left">4</td><td align="left">23</td><td align="left">1.60E−07</td><td char="." align="char">3.98</td></tr><tr><td align="left">Epithelial gene expression</td><td align="left">16</td><td align="left">36</td><td align="left">1.63E−07</td><td char="." align="char">2.77</td></tr><tr><td align="left">Smoking Status: Current, Never</td><td align="left">23</td><td align="left">35</td><td align="left">1.67E−07</td><td char="." align="char">2.82</td></tr><tr><td align="left">DE genes expressed in Healthy</td><td align="left">11</td><td align="left">35</td><td align="left">1.97E−07</td><td char="." align="char">2.80</td></tr><tr><td align="left">Echovirus-30</td><td align="left">1</td><td align="left">13</td><td align="left">2.33E−07</td><td char="." align="char">7.35</td></tr><tr><td align="left">Blood‚ÄìCerebrospinal Fluid Barrier</td><td align="left">1</td><td align="left">13</td><td align="left">2.33E−07</td><td char="." align="char">7.35</td></tr><tr><td align="left">Polar Infection</td><td align="left">1</td><td align="left">13</td><td align="left">2.33E−07</td><td char="." align="char">7.35</td></tr><tr><td align="left">Skeletal muscle gene expression</td><td align="left">2</td><td align="left">18</td><td align="left">3.23E−07</td><td char="." align="char">4.83</td></tr><tr><td align="left">Before vs After diet intake</td><td align="left">7</td><td align="left">23</td><td align="left">8.32E−07</td><td char="." align="char">3.60</td></tr><tr><td align="left">Pack-years: (20–30; Healthy smoker), (Above 40; Smoker with COPD)</td><td align="left">4</td><td align="left">18</td><td align="left">8.72E−07</td><td char="." align="char">4.50</td></tr><tr><td align="left">T effector cells</td><td align="left">2</td><td align="left">15</td><td align="left">1.08E−06</td><td char="." align="char">5.38</td></tr><tr><td align="left">Helminth infection</td><td align="left">2</td><td align="left">15</td><td align="left">1.08E−06</td><td char="." align="char">5.38</td></tr><tr><td align="left">Cell growth</td><td align="left">7</td><td align="left">15</td><td align="left">1.37E−06</td><td char="." align="char">5.27</td></tr><tr><td align="left">Macrophages gene expression</td><td align="left">4</td><td align="left">12</td><td align="left">1.40E−06</td><td char="." align="char">6.89</td></tr><tr><td align="left">Cell culture based smoking effect</td><td align="left">3</td><td align="left">13</td><td align="left">1.62E−06</td><td char="." align="char">6.12</td></tr><tr><td align="left">Cystic Fibrosis</td><td align="left">1</td><td align="left">24</td><td align="left">1.62E−06</td><td char="." align="char">3.33</td></tr><tr><td align="left">Rhinovirus infection</td><td align="left">1</td><td align="left">24</td><td align="left">1.62E−06</td><td char="." align="char">3.33</td></tr><tr><td align="left">Human choroid plexus epithelial cells</td><td align="left">1</td><td align="left">12</td><td align="left">1.79E−06</td><td char="." align="char">6.70</td></tr><tr><td align="left">Cytokines</td><td align="left">4</td><td align="left">15</td><td align="left">2.70E−06</td><td char="." align="char">4.96</td></tr><tr><td align="left">SIV infection</td><td align="left">6</td><td align="left">24</td><td align="left">2.81E−06</td><td char="." align="char">3.22</td></tr><tr><td align="left">Weight associated gene expression</td><td align="left">10</td><td align="left">16</td><td align="left">2.90E−06</td><td char="." align="char">4.59</td></tr><tr><td align="left">Polymorphonuclear leukocytes</td><td align="left">10</td><td align="left">48</td><td align="left">2.90E−06</td><td char="." align="char">2.07</td></tr><tr><td align="left">Anaplasma phagocytophilum</td><td align="left">10</td><td align="left">48</td><td align="left">2.90E−06</td><td char="." align="char">2.07</td></tr><tr><td align="left">Granulocytic anaplasmosis</td><td align="left">10</td><td align="left">48</td><td align="left">2.90E−06</td><td char="." align="char">2.07</td></tr><tr><td align="left">Ulcerative colitis</td><td align="left">1</td><td align="left">10</td><td align="left">3.48E−06</td><td char="." align="char">7.92</td></tr><tr><td align="left">Crohn's disease</td><td align="left">1</td><td align="left">10</td><td align="left">3.48E−06</td><td char="." align="char">7.92</td></tr><tr><td align="left">Jurkat cells gene expression</td><td align="left">1</td><td align="left">10</td><td align="left">3.48E−06</td><td char="." align="char">7.92</td></tr><tr><td align="left">Pack-years: (10–20)</td><td align="left">5</td><td align="left">16</td><td align="left">5.00E−06</td><td char="." align="char">4.38</td></tr><tr><td align="left">Diet intake: Dietary energy restriction</td><td align="left">3</td><td align="left">26</td><td align="left">5.00E−06</td><td char="." align="char">2.92</td></tr><tr><td align="left">Viral infection</td><td align="left">19</td><td align="left">62</td><td align="left">6.62E−06</td><td char="." align="char">1.78</td></tr><tr><td align="left">Signal Transduction</td><td align="left">7</td><td align="left">19</td><td align="left">9.18E−06</td><td char="." align="char">3.57</td></tr><tr><td align="left">Vesicular traffic</td><td align="left">1</td><td align="left">15</td><td align="left">1.32E−05</td><td char="." align="char">4.26</td></tr><tr><td align="left">DE genes expressed in Insulin sensitive individuals</td><td align="left">1</td><td align="left">15</td><td align="left">1.32E−05</td><td char="." align="char">4.26</td></tr><tr><td align="left">Protein Metabolism</td><td align="left">2</td><td align="left">15</td><td align="left">2.30E−05</td><td char="." align="char">4.04</td></tr><tr><td align="left">Idiopathic pulmonary fibrosis</td><td align="left">1</td><td align="left">14</td><td align="left">2.58E−05</td><td char="." align="char">4.26</td></tr><tr><td align="left">Lung cancer</td><td align="left">8</td><td align="left">23</td><td align="left">3.20E−05</td><td char="." align="char">2.81</td></tr><tr><td align="left">Oxidative stress</td><td align="left">11</td><td align="left">25</td><td align="left">3.26E−05</td><td char="." align="char">2.66</td></tr><tr><td align="left">Non-smoker vs Smoker (Healthy smoker, Smoker with COPD)</td><td align="left">11</td><td align="left">18</td><td align="left">4.67E−05</td><td char="." align="char">3.26</td></tr><tr><td align="left">Zika virus associated CD4T cell response</td><td align="left">1</td><td align="left">10</td><td align="left">1.23E−04</td><td char="." align="char">5.06</td></tr><tr><td align="left">Diet intake vs Control</td><td align="left">17</td><td align="left">19</td><td align="left">1.64E−04</td><td char="." align="char">2.83</td></tr><tr><td align="left">Cytoskeletal function</td><td align="left">3</td><td align="left">21</td><td align="left">1.72E−04</td><td char="." align="char">2.64</td></tr><tr><td align="left">Pathogen sensing</td><td align="left">6</td><td align="left">14</td><td align="left">3.90E−04</td><td char="." align="char">3.23</td></tr><tr><td align="left">Antimicrobial defense</td><td align="left">6</td><td align="left">14</td><td align="left">3.90E−04</td><td char="." align="char">3.23</td></tr><tr><td align="left">Supression of T cell activation</td><td align="left">6</td><td align="left">14</td><td align="left">3.90E−04</td><td char="." align="char">3.23</td></tr><tr><td align="left">Enhanced bactericidal activity</td><td align="left">6</td><td align="left">14</td><td align="left">3.90E−04</td><td char="." align="char">3.23</td></tr><tr><td align="left">Inhibition of granuloma destruction</td><td align="left">6</td><td align="left">14</td><td align="left">3.90E−04</td><td char="." align="char">3.23</td></tr><tr><td align="left">Viral responses</td><td align="left">4</td><td align="left">11</td><td align="left">4.20E−04</td><td char="." align="char">3.90</td></tr><tr><td align="left">Genotoxic</td><td align="left">2</td><td align="left">14</td><td align="left">4.28E−04</td><td char="." align="char">3.19</td></tr><tr><td align="left">Carcinogen</td><td align="left">2</td><td align="left">14</td><td align="left">4.28E−04</td><td char="." align="char">3.19</td></tr><tr><td align="left">Chemical induced gene expression</td><td align="left">3</td><td align="left">14</td><td align="left">5.13E−04</td><td char="." align="char">3.13</td></tr><tr><td align="left">Energy restriction associated gene expression</td><td align="left">2</td><td align="left">20</td><td align="left">7.40E−04</td><td char="." align="char">2.41</td></tr><tr><td align="left">Calorie restriction effect on old vs young</td><td align="left">1</td><td align="left">14</td><td align="left">1.07E−03</td><td char="." align="char">2.90</td></tr><tr><td align="left">Innate Immunity</td><td align="left">5</td><td align="left">46</td><td align="left">1.11E−03</td><td char="." align="char">1.63</td></tr><tr><td align="left">Regulatory T cells</td><td align="left">2</td><td align="left">10</td><td align="left">1.38E−03</td><td char="." align="char">3.60</td></tr><tr><td align="left">Immunopathology</td><td align="left">2</td><td align="left">10</td><td align="left">1.38E−03</td><td char="." align="char">3.60</td></tr><tr><td align="left">Helminth Infection</td><td align="left">2</td><td align="left">10</td><td align="left">1.38E−03</td><td char="." align="char">3.60</td></tr><tr><td align="left">Insulin resistance</td><td align="left">7</td><td align="left">67</td><td align="left">2.63E−03</td><td char="." align="char">1.40</td></tr><tr><td align="left">Diet intake: High-fat</td><td align="left">13</td><td align="left">19</td><td align="left">3.42E−03</td><td char="." align="char">2.16</td></tr><tr><td align="left">Non-genotoxic</td><td align="left">1</td><td align="left">12</td><td align="left">3.47E−03</td><td char="." align="char">2.79</td></tr><tr><td align="left">Hepatocarcinogens</td><td align="left">1</td><td align="left">12</td><td align="left">3.47E−03</td><td char="." align="char">2.79</td></tr><tr><td align="left">Liver-based in vitro models</td><td align="left">1</td><td align="left">12</td><td align="left">3.47E−03</td><td char="." align="char">2.79</td></tr><tr><td align="left">Immune response</td><td align="left">2</td><td align="left">36</td><td align="left">4.56E−03</td><td char="." align="char">1.64</td></tr><tr><td align="left">Dendritic cell maturation</td><td align="left">2</td><td align="left">36</td><td align="left">4.56E−03</td><td char="." align="char">1.64</td></tr><tr><td align="left">Newcastle disease virus</td><td align="left">2</td><td align="left">36</td><td align="left">4.56E−03</td><td char="." align="char">1.64</td></tr><tr><td align="left">Adipose tissue gene expression</td><td align="left">3</td><td align="left">64</td><td align="left">7.85E−03</td><td char="." align="char">1.36</td></tr><tr><td align="left">Mannose metabolism</td><td align="left">1</td><td align="left">63</td><td align="left">1.14E−02</td><td char="." align="char">1.34</td></tr><tr><td align="left">Hematogenous dissemination of virus</td><td align="left">6</td><td align="left">15</td><td align="left">1.54E−02</td><td char="." align="char">2.04</td></tr><tr><td align="left">Epidermal growth factor receptor/PI3K signaling pathway</td><td align="left">6</td><td align="left">15</td><td align="left">1.54E−02</td><td char="." align="char">2.04</td></tr><tr><td align="left">Obese vs Lean</td><td align="left">2</td><td align="left">63</td><td align="left">1.89E−02</td><td char="." align="char">1.31</td></tr><tr><td align="left">DE genes expressed in Obese, Lean</td><td align="left">3</td><td align="left">63</td><td align="left">1.90E−02</td><td char="." align="char">1.31</td></tr><tr><td align="left">Lipid induced gene expression</td><td align="left">1</td><td align="left">11</td><td align="left">2.42E−02</td><td char="." align="char">2.21</td></tr><tr><td align="left">CD4 + T cell</td><td align="left">7</td><td align="left">11</td><td align="left">2.53E−02</td><td char="." align="char">2.19</td></tr><tr><td align="left">Pack-years: (20–30)</td><td align="left">9</td><td align="left">16</td><td align="left">3.38E−02</td><td char="." align="char">1.80</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec17">
      <title>Case study 3: Regulation of the cell-cycle process in small cell lung cancer</title>
      <p id="Par32">We next studied gene modules associated with small cell lung cancer. The query signature containing 71 DE genes was derived from 23 clinical small cell lung cancer samples and 42 healthy control tissues<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. We found that several lungs cancer associated gene modules were infections were was the most common environmental factor associated with the DE genes statistically significant (Table <xref rid="Tab4" ref-type="table">4</xref>). The effect of Cigarette smoking (<italic>Tumor tissue vs Non tumor tissue in Non-smoker vs Smoker, Cigarette smoking, Smoking Status: Current, Never</italic>) was also evident. As expected, <italic>Lung tissue gene expression</italic> and <italic>Adenocarcinoma</italic> were amongst the top five gene modules, along with <italic>Cytoprotective mechanism</italic>, <italic>Mitotic spindle formation genes</italic> and <italic>Cell cycle</italic>, which are important pathways dysregulated in cancer (Table <xref rid="Tab4" ref-type="table">4</xref>). Other interesting gene modules that are known to be involved in lung cancer were also identified, including <italic>Lung cancer, Cigarette smoking, Airway epithelium</italic> and <italic>Immune response</italic>.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Collation of results obtained on query of E.PAGE with genes differentially expressed in small cell lung cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene modules</th><th align="left">Number of modules</th><th align="left">Number of DE genes</th><th align="left"><inline-formula id="IEq22"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M44"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq22.gif"/></alternatives></inline-formula></th><th align="left">Fold enrichment</th></tr></thead><tbody><tr><td align="left">Cytoprotective mechanism</td><td align="left">1</td><td align="left">21</td><td align="left">7.28E−08</td><td char="." align="char">5.33</td></tr><tr><td align="left">Mitotic spindle formation genes</td><td align="left">1</td><td align="left">10</td><td align="left">1.95E−07</td><td char="." align="char">15.80</td></tr><tr><td align="left">Cell cycle</td><td align="left">4</td><td align="left">10</td><td align="left">8.49E−07</td><td char="." align="char">12.98</td></tr><tr><td align="left">Lungs tissue gene expression</td><td align="left">2</td><td align="left">10</td><td align="left">8.49E−07</td><td char="." align="char">12.62</td></tr><tr><td align="left">Adenocarcinoma</td><td align="left">2</td><td align="left">10</td><td align="left">3.62E−04</td><td char="." align="char">6.39</td></tr><tr><td align="left">Tumor tissue vs Non tumor tissue in Non-smoker vs Smoker</td><td align="left">3</td><td align="left">10</td><td align="left">6.78E−04</td><td char="." align="char">5.82</td></tr><tr><td align="left">Apoptosis</td><td align="left">34</td><td align="left">34</td><td align="left">9.36E−04</td><td char="." align="char">1.97</td></tr><tr><td align="left">Smoking Status: Current, Former, Never</td><td align="left">5</td><td align="left">10</td><td align="left">1.21E−03</td><td char="." align="char">5.27</td></tr><tr><td align="left">Reactive oxygen species</td><td align="left">12</td><td align="left">23</td><td align="left">1.31E−03</td><td char="." align="char">2.47</td></tr><tr><td align="left">Polymorphonuclear leukocytes</td><td align="left">10</td><td align="left">22</td><td align="left">2.30E−03</td><td char="." align="char">2.39</td></tr><tr><td align="left">Anaplasma phagocytophilum</td><td align="left">10</td><td align="left">22</td><td align="left">2.30E−03</td><td char="." align="char">2.39</td></tr><tr><td align="left">Granulocytic anaplasmosis</td><td align="left">10</td><td align="left">22</td><td align="left">2.30E−03</td><td char="." align="char">2.39</td></tr><tr><td align="left">Cigarette smoking</td><td align="left">36</td><td align="left">23</td><td align="left">2.30E−03</td><td char="." align="char">2.35</td></tr><tr><td align="left">Macrophages</td><td align="left">17</td><td align="left">22</td><td align="left">2.38E−03</td><td char="." align="char">2.38</td></tr><tr><td align="left">Smoking Status: Current, Never</td><td align="left">23</td><td align="left">14</td><td align="left">1.10E−02</td><td char="." align="char">2.85</td></tr><tr><td align="left">Infection induced gene expression in mice</td><td align="left">18</td><td align="left">17</td><td align="left">1.35E−02</td><td char="." align="char">2.44</td></tr><tr><td align="left">Lung cancer</td><td align="left">8</td><td align="left">10</td><td align="left">4.05E−02</td><td char="." align="char">3.08</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec18">
      <title>Case study 4: Genotoxicity associated with cobalt exposed gene expression</title>
      <p id="Par33">We next used E.PAGE to understand the gene expression pathways involved in cobalt exposure. We used 27 DE genes uncovered by measuring the effect of cobalt exposure on gene expression in two rat liver derived cell lines using microarray analysis<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Cobalt exposed DE genes were associated with chemical induced gene expression. Other significant gene modules include <italic>genotoxicity, carcinogen, non-genotoxic, hepatocarcinogens,</italic> and <italic>liver-based </italic>in vitro<italic> models</italic> (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Collation of results obtained on query of E.PAGE with genes differentially expressed in cobalt exposure.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene modules</th><th align="left">Number of modules</th><th align="left">Number of DE genes</th><th align="left"><inline-formula id="IEq23"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M46"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq23.gif"/></alternatives></inline-formula></th><th align="left">Fold enrichment</th></tr></thead><tbody><tr><td align="left">Genotoxic</td><td align="left">2</td><td align="left">8</td><td align="left">1.84E−05</td><td char="." align="char">12.09</td></tr><tr><td align="left">Non-genotoxic</td><td align="left">1</td><td align="left">8</td><td align="left">1.84E−05</td><td char="." align="char">12.33</td></tr><tr><td align="left">Carcinogen</td><td align="left">2</td><td align="left">8</td><td align="left">1.84E−05</td><td char="." align="char">12.09</td></tr><tr><td align="left">Hepatocarcinogens</td><td align="left">1</td><td align="left">8</td><td align="left">1.84E−05</td><td char="." align="char">12.33</td></tr><tr><td align="left">Liver-based in vitro models</td><td align="left">1</td><td align="left">8</td><td align="left">1.84E−05</td><td char="." align="char">12.33</td></tr><tr><td align="left">Chemical induced gene expression</td><td align="left">3</td><td align="left">8</td><td align="left">1.84E−05</td><td char="." align="char">11.87</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec19">
      <title>Case study 5: Single-cell COVID-19 dataset</title>
      <p id="Par34">From a single-cell RNA sequencing dataset<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, we first conducted a standard Seurat pipeline to determine the graph based clusters<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. We then analysed enrichment of gene modules based on DE genes in Seurat clusters in COVID-19 and healthy cases. As expected, we identified <italic>COVID-19, SARS-COV2</italic> modules. Significant enrichment was also observed for the <italic>Inflammation, Infection-type: Acute, Immune response, Infection induced gene expression</italic> and <italic>Cigarette smoking</italic> amongst the top modules that were previously shown to be COVID-19-related<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> (Table <xref rid="Tab6" ref-type="table">6</xref>).<table-wrap id="Tab6"><label>Table 6</label><caption><p>Collation of results obtained on querying E.PAGE with genes differentially expressed in severe COVID-19.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene modules</th><th align="left">Number of modules</th><th align="left">Number of DE genes</th><th align="left"><inline-formula id="IEq24"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M48"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq24.gif"/></alternatives></inline-formula></th><th align="left">Fold enrichment</th></tr></thead><tbody><tr><td align="left">Inflammation</td><td align="left">31</td><td align="left">188</td><td align="left">1.18E−60</td><td char="." align="char">3.39</td></tr><tr><td align="left">Infection type: Acute</td><td align="left">58</td><td align="left">225</td><td align="left">1.02E−56</td><td char="." align="char">2.58</td></tr><tr><td align="left">Immune response</td><td align="left">46</td><td align="left">187</td><td align="left">7.61E−49</td><td char="." align="char">2.86</td></tr><tr><td align="left">Infection induced gene expression</td><td align="left">110</td><td align="left">273</td><td align="left">1.41E−44</td><td char="." align="char">1.79</td></tr><tr><td align="left">Interferons</td><td align="left">15</td><td align="left">123</td><td align="left">1.89E−43</td><td char="." align="char">4.11</td></tr><tr><td align="left">Cigarette smoking</td><td align="left">36</td><td align="left">143</td><td align="left">6.85E−41</td><td char="." align="char">3.31</td></tr><tr><td align="left">Chronic obstructive pulmonary disease</td><td align="left">16</td><td align="left">90</td><td align="left">1.80E−39</td><td char="." align="char">5.42</td></tr><tr><td align="left">PBMCs</td><td align="left">22</td><td align="left">139</td><td align="left">3.93E−37</td><td char="." align="char">3.15</td></tr><tr><td align="left">DE genes expressed in Obese</td><td align="left">15</td><td align="left">99</td><td align="left">2.19E−35</td><td char="." align="char">4.30</td></tr><tr><td align="left">Mycobacterium tuberculosis</td><td align="left">3</td><td align="left">49</td><td align="left">9.60E−35</td><td char="." align="char">11.09</td></tr><tr><td align="left">Non-smoker vs Smoker</td><td align="left">16</td><td align="left">105</td><td align="left">4.88E−34</td><td char="." align="char">3.88</td></tr><tr><td align="left">Infection type: Chronic</td><td align="left">29</td><td align="left">151</td><td align="left">3.17E−33</td><td char="." align="char">2.69</td></tr><tr><td align="left">Monocytes</td><td align="left">10</td><td align="left">87</td><td align="left">6.19E−33</td><td char="." align="char">4.61</td></tr><tr><td align="left">Macrophages</td><td align="left">17</td><td align="left">126</td><td align="left">5.42E−32</td><td char="." align="char">3.08</td></tr><tr><td align="left">IL-12</td><td align="left">4</td><td align="left">83</td><td align="left">1.20E−31</td><td char="." align="char">4.66</td></tr><tr><td align="left">Th1-mediated response</td><td align="left">4</td><td align="left">83</td><td align="left">1.20E−31</td><td char="." align="char">4.66</td></tr><tr><td align="left">Parasite killing</td><td align="left">4</td><td align="left">83</td><td align="left">1.20E−31</td><td char="." align="char">4.66</td></tr><tr><td align="left">Viral response</td><td align="left">9</td><td align="left">78</td><td align="left">1.05E−30</td><td char="." align="char">4.84</td></tr><tr><td align="left">Macrophages gene expression</td><td align="left">4</td><td align="left">39</td><td align="left">4.60E−30</td><td char="." align="char">12.77</td></tr><tr><td align="left">Lung cancer</td><td align="left">8</td><td align="left">73</td><td align="left">5.74E−30</td><td char="." align="char">5.09</td></tr><tr><td align="left">Mosquito-borne pathogen</td><td align="left">7</td><td align="left">74</td><td align="left">6.99E−30</td><td char="." align="char">4.99</td></tr><tr><td align="left">Zika 
virus</td><td align="left">8</td><td align="left">74</td><td align="left">1.72E−29</td><td char="." align="char">4.92</td></tr><tr><td align="left">Reactive oxygen species</td><td align="left">12</td><td align="left">121</td><td align="left">1.30E−28</td><td char="." align="char">2.93</td></tr><tr><td align="left">Diet intake: Dietary energy restriction</td><td align="left">3</td><td align="left">74</td><td align="left">1.55E−28</td><td char="." align="char">4.74</td></tr><tr><td align="left">Airway epithelium</td><td align="left">26</td><td align="left">118</td><td align="left">4.15E−27</td><td char="." align="char">2.88</td></tr><tr><td align="left">Plasmodium falciparum</td><td align="left">1</td><td align="left">46</td><td align="left">3.05E−25</td><td char="." align="char">7.43</td></tr><tr><td align="left">Malaria</td><td align="left">1</td><td align="left">46</td><td align="left">3.05E−25</td><td char="." align="char">7.43</td></tr><tr><td align="left">Blood monocytes</td><td align="left">1</td><td align="left">46</td><td align="left">3.05E−25</td><td char="." align="char">7.43</td></tr><tr><td align="left">Metabolism</td><td align="left">7</td><td align="left">82</td><td align="left">4.91E−25</td><td char="." align="char">3.76</td></tr><tr><td align="left">Pack-years: (10–20)</td><td align="left">5</td><td align="left">46</td><td align="left">1.16E−24</td><td char="." align="char">7.19</td></tr><tr><td align="left">Polymorphonuclear leukocytes</td><td align="left">10</td><td align="left">112</td><td align="left">7.05E−24</td><td char="." align="char">2.76</td></tr><tr><td align="left">Anaplasma phagocytophilum</td><td align="left">10</td><td align="left">112</td><td align="left">7.05E−24</td><td char="." align="char">2.76</td></tr><tr><td align="left">Granulocytic anaplasmosis</td><td align="left">10</td><td align="left">112</td><td align="left">7.05E−24</td><td char="." align="char">2.76</td></tr><tr><td align="left">Bone marrow monocytes</td><td align="left">1</td><td align="left">28</td><td align="left">1.65E−23</td><td char="." align="char">14.75</td></tr><tr><td align="left">Myelodysplastic syndromes</td><td align="left">1</td><td align="left">28</td><td align="left">1.65E−23</td><td char="." align="char">14.75</td></tr><tr><td align="left">Hematopoietic stem cell disease</td><td align="left">1</td><td align="left">28</td><td align="left">1.65E−23</td><td char="." align="char">14.75</td></tr><tr><td align="left">Apoptosis</td><td align="left">34</td><td align="left">159</td><td align="left">4.18E−23</td><td char="." align="char">2.09</td></tr><tr><td align="left">Energy restriction associated gene expression</td><td align="left">2</td><td align="left">64</td><td align="left">8.15E−23</td><td char="." align="char">4.40</td></tr><tr><td align="left">Idiopathic pulmonary fibrosis</td><td align="left">1</td><td align="left">42</td><td align="left">8.63E−23</td><td char="." align="char">7.28</td></tr><tr><td align="left">Smoking Status: Current, Never</td><td align="left">23</td><td align="left">78</td><td align="left">1.41E−22</td><td char="." align="char">3.59</td></tr><tr><td align="left">Epithelial gene expression</td><td align="left">16</td><td align="left">79</td><td align="left">5.50E−22</td><td char="." align="char">3.47</td></tr><tr><td align="left">Dendritic cells</td><td align="left">20</td><td align="left">144</td><td align="left">5.52E−21</td><td char="." align="char">2.13</td></tr><tr><td align="left">Lyme disease</td><td align="left">2</td><td align="left">40</td><td align="left">7.47E−21</td><td char="." align="char">6.89</td></tr><tr><td align="left">Borrelia burgdorferi</td><td align="left">2</td><td align="left">40</td><td align="left">7.47E−21</td><td char="." align="char">6.89</td></tr><tr><td align="left">Hepatocellular carcinoma</td><td align="left">1</td><td align="left">69</td><td align="left">1.70E−20</td><td char="." align="char">3.69</td></tr><tr><td align="left">HBV Infection</td><td align="left">1</td><td align="left">69</td><td align="left">1.70E−20</td><td char="." align="char">3.69</td></tr><tr><td align="left">Blood immune cells</td><td align="left">20</td><td align="left">85</td><td align="left">5.45E−20</td><td char="." align="char">3.02</td></tr><tr><td align="left">Influenza A Infection</td><td align="left">20</td><td align="left">85</td><td align="left">5.45E−20</td><td char="." align="char">3.02</td></tr><tr><td align="left">E. coli infection</td><td align="left">20</td><td align="left">85</td><td align="left">5.45E−20</td><td char="." align="char">3.02</td></tr><tr><td align="left">Staphylococcus aureus infection</td><td align="left">20</td><td align="left">85</td><td align="left">5.45E−20</td><td char="." align="char">3.02</td></tr><tr><td align="left">Streptococcus pneumoniae infection</td><td align="left">20</td><td align="left">85</td><td align="left">5.45E−20</td><td char="." align="char">3.02</td></tr><tr><td align="left">Chemokines</td><td align="left">2</td><td align="left">24</td><td align="left">5.79E−20</td><td char="." align="char">14.29</td></tr><tr><td align="left">Central nervous system</td><td align="left">4</td><td align="left">35</td><td align="left">5.94E−20</td><td char="." align="char">7.75</td></tr><tr><td align="left">Zika virus associated pDCs response</td><td align="left">1</td><td align="left">32</td><td align="left">7.36E−20</td><td char="." align="char">8.77</td></tr><tr><td align="left">Pack-years: (20–30; Healthy smoker), (Above 40; Smoker with COPD)</td><td align="left">4</td><td align="left">42</td><td align="left">1.05E−19</td><td char="." align="char">5.99</td></tr><tr><td align="left">Tissue remodeling</td><td align="left">1</td><td align="left">19</td><td align="left">1.94E−19</td><td char="." align="char">21.39</td></tr><tr><td align="left">Immunoregulation</td><td align="left">1</td><td align="left">19</td><td align="left">1.94E−19</td><td char="." align="char">21.39</td></tr><tr><td align="left">Sepsis</td><td align="left">1</td><td align="left">17</td><td align="left">7.12E−19</td><td char="." align="char">25.40</td></tr><tr><td align="left">CD14 + Monocytes</td><td align="left">1</td><td align="left">17</td><td align="left">7.12E−19</td><td char="." align="char">25.40</td></tr><tr><td align="left">Innate immune response</td><td align="left">1</td><td align="left">17</td><td align="left">7.12E−19</td><td char="." align="char">25.40</td></tr><tr><td align="left">Fatty acid metabolism</td><td align="left">3</td><td align="left">17</td><td align="left">1.15E−16</td><td char="." align="char">19.41</td></tr><tr><td align="left">Non-smoker vs Smoker (Healthy smoker, Smoker with COPD)</td><td align="left">11</td><td align="left">44</td><td align="left">4.18E−16</td><td char="." align="char">4.54</td></tr><tr><td align="left">Bacterial infection</td><td align="left">4</td><td align="left">38</td><td align="left">7.17E−16</td><td char="." align="char">5.22</td></tr><tr><td align="left">Early Disseminated</td><td align="left">1</td><td align="left">25</td><td align="left">9.19E−16</td><td char="." align="char">8.89</td></tr><tr><td align="left">Bronchoalveolar epithelium</td><td align="left">1</td><td align="left">13</td><td align="left">1.04E−14</td><td char="." align="char">26.06</td></tr><tr><td align="left">Olive oil induced gene expression</td><td align="left">3</td><td align="left">21</td><td align="left">5.82E−14</td><td char="." align="char">9.59</td></tr><tr><td align="left">HIV infection</td><td align="left">9</td><td align="left">51</td><td align="left">8.54E−14</td><td char="." align="char">3.44</td></tr><tr><td align="left">SARS-COV2</td><td align="left">3</td><td align="left">18</td><td align="left">5.31E−13</td><td char="." align="char">10.88</td></tr><tr><td align="left">COVID-19</td><td align="left">3</td><td align="left">18</td><td align="left">5.31E−13</td><td char="." align="char">10.88</td></tr><tr><td align="left">Infection induced gene expression in mice</td><td align="left">18</td><td align="left">76</td><td align="left">5.83E−13</td><td char="." align="char">2.46</td></tr><tr><td align="left">Astrocytes</td><td align="left">2</td><td align="left">16</td><td align="left">6.21E−13</td><td char="." align="char">13.15</td></tr><tr><td align="left">Citric acid cycle</td><td align="left">1</td><td align="left">13</td><td align="left">8.34E−13</td><td char="." align="char">19.08</td></tr><tr><td align="left">Complement system</td><td align="left">1</td><td align="left">13</td><td align="left">8.34E−13</td><td char="." align="char">19.08</td></tr><tr><td align="left">Diet intake: Milk fat and protein</td><td align="left">1</td><td align="left">13</td><td align="left">8.34E−13</td><td char="." align="char">19.08</td></tr><tr><td align="left">Apopotosis</td><td align="left">1</td><td align="left">13</td><td align="left">3.39E−12</td><td char="." align="char">17.23</td></tr><tr><td align="left">Human gingival fibroblasts</td><td align="left">2</td><td align="left">13</td><td align="left">4.17E−12</td><td char="." align="char">16.96</td></tr><tr><td align="left">Transcription regulation</td><td align="left">11</td><td align="left">45</td><td align="left">6.79E−12</td><td char="." align="char">3.37</td></tr><tr><td align="left">Diet intake: Olive oil</td><td align="left">2</td><td align="left">18</td><td align="left">9.01E−12</td><td char="." align="char">9.19</td></tr><tr><td align="left">Oxidative stress</td><td align="left">11</td><td align="left">50</td><td align="left">1.57E−11</td><td char="." align="char">3.03</td></tr><tr><td align="left">Dyslipemia</td><td align="left">1</td><td align="left">15</td><td align="left">1.60E−11</td><td char="." align="char">11.85</td></tr><tr><td align="left">Fusobacterium nucleatum</td><td align="left">3</td><td align="left">16</td><td align="left">1.89E−11</td><td char="." align="char">10.52</td></tr><tr><td align="left">Oral pathogen</td><td align="left">3</td><td align="left">16</td><td align="left">1.89E−11</td><td char="." align="char">10.52</td></tr><tr><td align="left">Pro-inflammatory response</td><td align="left">1</td><td align="left">14</td><td align="left">2.47E−11</td><td char="." align="char">12.93</td></tr><tr><td align="left">Atheroscleorsis</td><td align="left">1</td><td align="left">10</td><td align="left">2.67E−11</td><td char="." align="char">24.91</td></tr><tr><td align="left">Atherosclerotic cardiovascular disease (ASCVD)</td><td align="left">1</td><td align="left">10</td><td align="left">2.67E−11</td><td char="." align="char">24.91</td></tr><tr><td align="left">Aging</td><td align="left">1</td><td align="left">10</td><td align="left">2.67E−11</td><td char="." align="char">24.91</td></tr><tr><td align="left">T effector cells</td><td align="left">2</td><td align="left">26</td><td align="left">3.15E−11</td><td char="." align="char">5.32</td></tr><tr><td align="left">Helminth infection</td><td align="left">2</td><td align="left">26</td><td align="left">3.15E−11</td><td char="." align="char">5.32</td></tr><tr><td align="left">Smoking Status: Current, Former, Never</td><td align="left">5</td><td align="left">34</td><td align="left">3.20E−11</td><td char="." align="char">4.05</td></tr><tr><td align="left">Oxidative phosphorylation</td><td align="left">3</td><td align="left">13</td><td align="left">2.25E−10</td><td char="." align="char">12.42</td></tr><tr><td align="left">Tumor tissue vs Non tumor tissue in Non-smoker vs Smoker</td><td align="left">3</td><td align="left">31</td><td align="left">2.34E−10</td><td char="." align="char">4.08</td></tr><tr><td align="left">Xenobiotic metabolism</td><td align="left">4</td><td align="left">30</td><td align="left">3.13E−10</td><td char="." align="char">4.16</td></tr><tr><td align="left">Human choroid plexus epithelial cells</td><td align="left">1</td><td align="left">20</td><td align="left">3.73E−10</td><td char="." align="char">6.37</td></tr><tr><td align="left">Adenocarcinoma</td><td align="left">2</td><td align="left">29</td><td align="left">5.47E−10</td><td char="." align="char">4.19</td></tr><tr><td align="left">Pack-years: (20–30)</td><td align="left">9</td><td align="left">45</td><td align="left">8.40E−10</td><td char="." align="char">2.89</td></tr><tr><td align="left">Regulatory T cells</td><td align="left">2</td><td align="left">24</td><td align="left">8.95E−10</td><td char="." align="char">4.93</td></tr><tr><td align="left">Immunopathology</td><td align="left">2</td><td align="left">24</td><td align="left">8.95E−10</td><td char="." align="char">4.93</td></tr><tr><td align="left">Helminth Infection</td><td align="left">2</td><td align="left">24</td><td align="left">8.95E−10</td><td char="." align="char">4.93</td></tr><tr><td align="left">Cell culture based smoking effect</td><td align="left">3</td><td align="left">21</td><td align="left">1.12E−09</td><td char="." align="char">5.64</td></tr><tr><td align="left">Hematopoiesis</td><td align="left">2</td><td align="left">28</td><td align="left">1.92E−09</td><td char="." align="char">4.09</td></tr><tr><td align="left">Signal Transduction</td><td align="left">7</td><td align="left">33</td><td align="left">2.01E−09</td><td char="." align="char">3.54</td></tr><tr><td align="left">Cystic Fibrosis</td><td align="left">1</td><td align="left">39</td><td align="left">2.33E−09</td><td char="." align="char">3.09</td></tr><tr><td align="left">Rhinovirus infection</td><td align="left">1</td><td align="left">39</td><td align="left">2.33E−09</td><td char="." align="char">3.09</td></tr><tr><td align="left">Angiogenesis</td><td align="left">2</td><td align="left">14</td><td align="left">2.35E−09</td><td char="." align="char">9.13</td></tr><tr><td align="left">Extracellular matrix metabolism</td><td align="left">1</td><td align="left">10</td><td align="left">3.66E−09</td><td char="." align="char">15.51</td></tr><tr><td align="left">Autosomal-dominant hyper-IgE syndrome</td><td align="left">1</td><td align="left">10</td><td align="left">3.66E−09</td><td char="." align="char">15.51</td></tr><tr><td align="left">Immunodeficiency</td><td align="left">1</td><td align="left">10</td><td align="left">3.66E−09</td><td char="." align="char">15.51</td></tr><tr><td align="left">Lipid metabolism</td><td align="left">9</td><td align="left">58</td><td align="left">3.95E−09</td><td char="." align="char">2.35</td></tr><tr><td align="left">Vascularization</td><td align="left">1</td><td align="left">27</td><td align="left">5.71E−09</td><td char="." align="char">4.01</td></tr><tr><td align="left">Oxidant-related</td><td align="left">2</td><td align="left">13</td><td align="left">9.38E−09</td><td char="." align="char">9.13</td></tr><tr><td align="left">Zika virus associated mDCs response</td><td align="left">1</td><td align="left">19</td><td align="left">2.74E−08</td><td char="." align="char">5.21</td></tr><tr><td align="left">Maternal cigarette smoking</td><td align="left">2</td><td align="left">27</td><td align="left">3.99E−08</td><td char="." align="char">3.65</td></tr><tr><td align="left">Cell death</td><td align="left">1</td><td align="left">20</td><td align="left">8.38E−08</td><td char="." align="char">4.60</td></tr><tr><td align="left">Leptin resistance</td><td align="left">1</td><td align="left">11</td><td align="left">9.12E−08</td><td char="." align="char">9.62</td></tr><tr><td align="left">Weight loss</td><td align="left">2</td><td align="left">11</td><td align="left">3.15E−07</td><td char="." align="char">8.53</td></tr><tr><td align="left">Gene expression induced due to fasting</td><td align="left">3</td><td align="left">13</td><td align="left">3.26E−07</td><td char="." align="char">6.76</td></tr><tr><td align="left">Diet intake: Fasting</td><td align="left">3</td><td align="left">13</td><td align="left">3.26E−07</td><td char="." align="char">6.76</td></tr><tr><td align="left">DE genes expressed in Healthy</td><td align="left">11</td><td align="left">49</td><td align="left">3.99E−07</td><td char="." align="char">2.24</td></tr><tr><td align="left">Cytokines</td><td align="left">4</td><td align="left">21</td><td align="left">4.55E−07</td><td char="." align="char">3.96</td></tr><tr><td align="left">Diet intake: Low calorie diet</td><td align="left">4</td><td align="left">30</td><td align="left">5.45E−07</td><td char="." align="char">2.96</td></tr><tr><td align="left">SIV infection</td><td align="left">6</td><td align="left">35</td><td align="left">5.45E−07</td><td char="." align="char">2.68</td></tr><tr><td align="left">Zika virus associated CD8T cell response</td><td align="left">1</td><td align="left">16</td><td align="left">1.24E−06</td><td char="." align="char">4.78</td></tr><tr><td align="left">Type 2 Diabetes</td><td align="left">5</td><td align="left">19</td><td align="left">1.44E−06</td><td char="." align="char">4.01</td></tr><tr><td align="left">Ulcerative colitis</td><td align="left">1</td><td align="left">13</td><td align="left">1.57E−06</td><td char="." align="char">5.87</td></tr><tr><td align="left">Crohn's disease</td><td align="left">1</td><td align="left">13</td><td align="left">1.57E−06</td><td char="." align="char">5.87</td></tr><tr><td align="left">Jurkat cells gene expression</td><td align="left">1</td><td align="left">13</td><td align="left">1.57E−06</td><td char="." align="char">5.87</td></tr><tr><td align="left">DNA damage</td><td align="left">3</td><td align="left">10</td><td align="left">3.48E−06</td><td char="." align="char">7.54</td></tr><tr><td align="left">Weight associated gene expression</td><td align="left">10</td><td align="left">21</td><td align="left">4.12E−06</td><td char="." align="char">3.44</td></tr><tr><td align="left">Obese vs Lean</td><td align="left">2</td><td align="left">123</td><td align="left">4.99E−06</td><td char="." align="char">1.46</td></tr><tr><td align="left">DE genes expressed in Obese, Lean</td><td align="left">3</td><td align="left">123</td><td align="left">5.04E−06</td><td char="." align="char">1.46</td></tr><tr><td align="left">Adipose tissue gene expression</td><td align="left">3</td><td align="left">121</td><td align="left">5.21E−06</td><td char="." align="char">1.46</td></tr><tr><td align="left">Chemical induced gene expression</td><td align="left">3</td><td align="left">24</td><td align="left">5.25E−06</td><td char="." align="char">3.06</td></tr><tr><td align="left">Insulin resistance</td><td align="left">7</td><td align="left">122</td><td align="left">5.28E−06</td><td char="." align="char">1.46</td></tr><tr><td align="left">Genotoxic</td><td align="left">2</td><td align="left">23</td><td align="left">1.27E−05</td><td char="." align="char">2.99</td></tr><tr><td align="left">Carcinogen</td><td align="left">2</td><td align="left">23</td><td align="left">1.27E−05</td><td char="." align="char">2.99</td></tr><tr><td align="left">Mannose metabolism</td><td align="left">1</td><td align="left">119</td><td align="left">1.31E−05</td><td char="." align="char">1.44</td></tr><tr><td align="left">Smoking History: &gt; 19 years</td><td align="left">2</td><td align="left">12</td><td align="left">1.59E−05</td><td char="." align="char">5.14</td></tr><tr><td align="left">Pack-days: (1–1.21)</td><td align="left">2</td><td align="left">12</td><td align="left">1.59E−05</td><td char="." align="char">5.14</td></tr><tr><td align="left">Calorie restriction effect on old vs young</td><td align="left">1</td><td align="left">24</td><td align="left">1.87E−05</td><td char="." align="char">2.83</td></tr><tr><td align="left">Diet intake vs Control</td><td align="left">17</td><td align="left">29</td><td align="left">2.83E−05</td><td char="." align="char">2.46</td></tr><tr><td align="left">Non-genotoxic</td><td align="left">1</td><td align="left">22</td><td align="left">2.84E−05</td><td char="." align="char">2.92</td></tr><tr><td align="left">Hepatocarcinogens</td><td align="left">1</td><td align="left">22</td><td align="left">2.84E−05</td><td char="." align="char">2.92</td></tr><tr><td align="left">Liver-based in vitro models</td><td align="left">1</td><td align="left">22</td><td align="left">2.84E−05</td><td char="." align="char">2.92</td></tr><tr><td align="left">Cell cycle</td><td align="left">4</td><td align="left">14</td><td align="left">3.19E−05</td><td char="." align="char">4.11</td></tr><tr><td align="left">Zika virus associated CD4T cell response</td><td align="left">1</td><td align="left">14</td><td align="left">3.81E−05</td><td char="." align="char">4.04</td></tr><tr><td align="left">Viral responses</td><td align="left">4</td><td align="left">17</td><td align="left">3.81E−05</td><td char="." align="char">3.43</td></tr><tr><td align="left">Cigarette smoking in women</td><td align="left">3</td><td align="left">13</td><td align="left">4.07E−05</td><td char="." align="char">4.29</td></tr><tr><td align="left">Lungs tissue gene expression</td><td align="left">2</td><td align="left">14</td><td align="left">4.20E−05</td><td char="." align="char">4.00</td></tr><tr><td align="left">HIV-1 infection</td><td align="left">9</td><td align="left">30</td><td align="left">4.20E−05</td><td char="." align="char">2.36</td></tr><tr><td align="left">Smoking Status: Current, Former</td><td align="left">2</td><td align="left">14</td><td align="left">5.33E−05</td><td char="." align="char">3.90</td></tr><tr><td align="left">Tumor tissue vs Non tumor tissue in Current smoker vs Former Smoker</td><td align="left">2</td><td align="left">14</td><td align="left">5.33E−05</td><td char="." align="char">3.90</td></tr><tr><td align="left">Zika virus induced B cell response</td><td align="left">1</td><td align="left">14</td><td align="left">6.10E−05</td><td char="." align="char">3.84</td></tr><tr><td align="left">Zika virus associated B cell response</td><td align="left">1</td><td align="left">14</td><td align="left">6.10E−05</td><td char="." align="char">3.84</td></tr><tr><td align="left">Zika virus associated monocytes response</td><td align="left">1</td><td align="left">14</td><td align="left">6.10E−05</td><td char="." align="char">3.84</td></tr><tr><td align="left">Mitotic spindle formation genes</td><td align="left">1</td><td align="left">12</td><td align="left">7.90E−05</td><td char="." align="char">4.29</td></tr><tr><td align="left">Skeletal muscle gene expression</td><td align="left">2</td><td align="left">19</td><td align="left">1.04E−04</td><td char="." align="char">2.91</td></tr><tr><td align="left">Metabolic pathways</td><td align="left">2</td><td align="left">10</td><td align="left">1.64E−04</td><td char="." align="char">4.70</td></tr><tr><td align="left">Innate Immunity</td><td align="left">5</td><td align="left">75</td><td align="left">2.77E−04</td><td char="." align="char">1.52</td></tr><tr><td align="left">Pulmonary nontuberculous mycobacterial disease</td><td align="left">1</td><td align="left">10</td><td align="left">6.57E−04</td><td char="." align="char">3.93</td></tr><tr><td align="left">T cell signaling</td><td align="left">1</td><td align="left">10</td><td align="left">6.57E−04</td><td char="." align="char">3.93</td></tr><tr><td align="left">Before vs After diet intake</td><td align="left">7</td><td align="left">24</td><td align="left">1.03E−03</td><td char="." align="char">2.14</td></tr><tr><td align="left">Protein Metabolism</td><td align="left">2</td><td align="left">16</td><td align="left">2.17E−03</td><td char="." align="char">2.46</td></tr><tr><td align="left">Vesicular traffic</td><td align="left">1</td><td align="left">15</td><td align="left">3.42E−03</td><td char="." align="char">2.43</td></tr><tr><td align="left">DE genes expressed in Insulin sensitive individuals</td><td align="left">1</td><td align="left">15</td><td align="left">3.42E−03</td><td char="." align="char">2.43</td></tr><tr><td align="left">DNA Methylation</td><td align="left">5</td><td align="left">11</td><td align="left">4.73E−03</td><td char="." align="char">2.80</td></tr><tr><td align="left">CD4 + T cell</td><td align="left">7</td><td align="left">17</td><td align="left">1.54E−02</td><td char="." align="char">1.93</td></tr><tr><td align="left">Hematogenous dissemination of virus</td><td align="left">6</td><td align="left">22</td><td align="left">2.11E−02</td><td char="." align="char">1.71</td></tr><tr><td align="left">Epidermal growth factor receptor/PI3K signaling pathway</td><td align="left">6</td><td align="left">22</td><td align="left">2.11E−02</td><td char="." align="char">1.71</td></tr><tr><td align="left">Cytoskeletal function</td><td align="left">3</td><td align="left">23</td><td align="left">2.54E−02</td><td char="." align="char">1.65</td></tr><tr><td align="left">Cytoprotective mechanism</td><td align="left">1</td><td align="left">27</td><td align="left">3.10E−02</td><td char="." align="char">1.55</td></tr><tr><td align="left">Cell-adhesion</td><td align="left">3</td><td align="left">16</td><td align="left">3.67E−02</td><td char="." align="char">1.78</td></tr><tr><td align="left">Diet intake: High-fat</td><td align="left">13</td><td align="left">24</td><td align="left">4.03E−02</td><td char="." align="char">1.56</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec20">
      <title>Case study 6: Single-cell smoking dataset</title>
      <p id="Par35">As a sixth case study, we attempted to identify enriched gene modules related to smoking using a single cell RNA sequencing dataset which contained data of smokers vs non-smokers<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. After processing the data using the Seurat pipeline and analyzing the single-cell expression data, gene set enrichment identified <italic>Epithelial gene expression, Cigarette smoking</italic>, <italic>Airway epithelium</italic>, and <italic>Chronic obstructive pulmonary disease</italic> as the top gene modules with highly significant p-values, confirming that smoking-related pathways were correctly predicted using E.PAGE (Table <xref rid="Tab7" ref-type="table">7</xref>). Furthermore, smoking associated with gene signatures of lung-associated diseases such as <italic>Lung cancer</italic>, <italic>Cystic fibrosis</italic>, as well as with <italic>Carcinogen</italic> and respiratory infections such as <italic>Influenza</italic> and <italic>COVID-19</italic>.<table-wrap id="Tab7"><label>Table 7</label><caption><p>Collation of results obtained on querying E.PAGE with genes differentially expressed in heavy smoking subjects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene modules</th><th align="left">Number of modules</th><th align="left">Number of DE genes</th><th align="left"><inline-formula id="IEq25"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{adj}$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">adj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_21988_Article_IEq25.gif"/></alternatives></inline-formula></th><th align="left">Fold enrichment</th></tr></thead><tbody><tr><td align="left">Epithelial gene expression</td><td align="left">16</td><td align="left">198</td><td align="left">3.07E−87</td><td char="." align="char">5.16</td></tr><tr><td align="left">Cigarette smoking</td><td align="left">36</td><td align="left">261</td><td align="left">6.38E−85</td><td char="." align="char">3.58</td></tr><tr><td align="left">Airway epithelium</td><td align="left">26</td><td align="left">254</td><td align="left">7.98E−85</td><td char="." align="char">3.68</td></tr><tr><td align="left">Non-smoker vs Smoker</td><td align="left">16</td><td align="left">206</td><td align="left">3.08E−81</td><td char="." align="char">4.52</td></tr><tr><td align="left">Idiopathic pulmonary fibrosis</td><td align="left">1</td><td align="left">103</td><td align="left">2.05E−73</td><td char="." align="char">10.60</td></tr><tr><td align="left">Chronic obstructive pulmonary disease</td><td align="left">16</td><td align="left">158</td><td align="left">2.05E−73</td><td char="." align="char">5.64</td></tr><tr><td align="left">Pack-years: (10–20)</td><td align="left">5</td><td align="left">105</td><td align="left">4.99E−71</td><td char="." align="char">9.74</td></tr><tr><td align="left">Lung cancer</td><td align="left">8</td><td align="left">136</td><td align="left">4.78E−62</td><td char="." align="char">5.63</td></tr><tr><td align="left">Smoking Status: Current, Never</td><td align="left">23</td><td align="left">141</td><td align="left">3.87E−44</td><td char="." align="char">3.85</td></tr><tr><td align="left">Pack-years: (20–30)</td><td align="left">9</td><td align="left">113</td><td align="left">3.95E−39</td><td char="." align="char">4.31</td></tr><tr><td align="left">Infection type: Acute</td><td align="left">58</td><td align="left">276</td><td align="left">3.54E−31</td><td char="." align="char">1.88</td></tr><tr><td align="left">Infection induced gene expression</td><td align="left">110</td><td align="left">390</td><td align="left">1.15E−30</td><td char="." align="char">1.51</td></tr><tr><td align="left">Inflammation</td><td align="left">31</td><td align="left">207</td><td align="left">2.15E−30</td><td char="." align="char">2.21</td></tr><tr><td align="left">Immune response</td><td align="left">46</td><td align="left">214</td><td align="left">1.04E−23</td><td char="." align="char">1.94</td></tr><tr><td align="left">Infection type: Chronic</td><td align="left">29</td><td align="left">192</td><td align="left">8.61E−23</td><td char="." align="char">2.03</td></tr><tr><td align="left">Apoptosis</td><td align="left">34</td><td align="left">233</td><td align="left">2.18E−22</td><td char="." align="char">1.82</td></tr><tr><td align="left">Transcription regulation</td><td align="left">11</td><td align="left">77</td><td align="left">8.42E−20</td><td char="." align="char">3.42</td></tr><tr><td align="left">Cystic Fibrosis</td><td align="left">1</td><td align="left">74</td><td align="left">1.82E−19</td><td char="." align="char">3.48</td></tr><tr><td align="left">Rhinovirus infection</td><td align="left">1</td><td align="left">74</td><td align="left">1.82E−19</td><td char="." align="char">3.48</td></tr><tr><td align="left">Lyme disease</td><td align="left">2</td><td align="left">48</td><td align="left">2.39E−18</td><td char="." align="char">4.91</td></tr><tr><td align="left">Borrelia burgdorferi</td><td align="left">2</td><td align="left">48</td><td align="left">2.39E−18</td><td char="." align="char">4.91</td></tr><tr><td align="left">Non-smoker vs Smoker (Healthy smoker, Smoker with COPD)</td><td align="left">11</td><td align="left">62</td><td align="left">4.36E−18</td><td char="." align="char">3.79</td></tr><tr><td align="left">Lipid metabolism</td><td align="left">9</td><td align="left">106</td><td align="left">4.56E−18</td><td char="." align="char">2.55</td></tr><tr><td align="left">Reactive oxygen species</td><td align="left">12</td><td align="left">146</td><td align="left">8.89E−18</td><td char="." align="char">2.10</td></tr><tr><td align="left">PBMCs</td><td align="left">22</td><td align="left">152</td><td align="left">1.48E−17</td><td char="." align="char">2.04</td></tr><tr><td align="left">Mycobacterium tuberculosis</td><td align="left">3</td><td align="left">41</td><td align="left">1.59E−17</td><td char="." align="char">5.51</td></tr><tr><td align="left">Pack-years: (20–30; Healthy smoker), (Above 40; Smoker with COPD)</td><td align="left">4</td><td align="left">51</td><td align="left">3.22E−17</td><td char="." align="char">4.32</td></tr><tr><td align="left">Macrophages</td><td align="left">17</td><td align="left">143</td><td align="left">6.22E−17</td><td char="." align="char">2.07</td></tr><tr><td align="left">Infection induced gene expression in mice</td><td align="left">18</td><td align="left">119</td><td align="left">6.23E−17</td><td char="." align="char">2.29</td></tr><tr><td align="left">Interferons</td><td align="left">15</td><td align="left">115</td><td align="left">3.24E−16</td><td char="." align="char">2.28</td></tr><tr><td align="left">Polymorphonuclear leukocytes</td><td align="left">10</td><td align="left">138</td><td align="left">2.89E−15</td><td char="." align="char">2.02</td></tr><tr><td align="left">Anaplasma phagocytophilum</td><td align="left">10</td><td align="left">138</td><td align="left">2.89E−15</td><td char="." align="char">2.02</td></tr><tr><td align="left">Granulocytic anaplasmosis</td><td align="left">10</td><td align="left">138</td><td align="left">2.89E−15</td><td char="." align="char">2.02</td></tr><tr><td align="left">Central nervous system</td><td align="left">4</td><td align="left">38</td><td align="left">6.33E−15</td><td char="." align="char">5.00</td></tr><tr><td align="left">Oxidative stress</td><td align="left">11</td><td align="left">77</td><td align="left">7.09E−15</td><td char="." align="char">2.77</td></tr><tr><td align="left">HIV infection</td><td align="left">9</td><td align="left">72</td><td align="left">9.37E−15</td><td char="." align="char">2.88</td></tr><tr><td align="left">Signal Transduction</td><td align="left">7</td><td align="left">55</td><td align="left">1.14E−14</td><td char="." align="char">3.50</td></tr><tr><td align="left">Hepatocellular carcinoma</td><td align="left">1</td><td align="left">82</td><td align="left">1.93E−14</td><td char="." align="char">2.61</td></tr><tr><td align="left">HBV Infection</td><td align="left">1</td><td align="left">82</td><td align="left">1.93E−14</td><td char="." align="char">2.61</td></tr><tr><td align="left">Human choroid plexus epithelial cells</td><td align="left">1</td><td align="left">30</td><td align="left">2.52E−13</td><td char="." align="char">5.67</td></tr><tr><td align="left">IL-12</td><td align="left">4</td><td align="left">76</td><td align="left">1.01E−12</td><td char="." align="char">2.53</td></tr><tr><td align="left">Th1-mediated response</td><td align="left">4</td><td align="left">76</td><td align="left">1.01E−12</td><td char="." align="char">2.53</td></tr><tr><td align="left">Parasite killing</td><td align="left">4</td><td align="left">76</td><td align="left">1.01E−12</td><td char="." align="char">2.53</td></tr><tr><td align="left">Monocytes</td><td align="left">10</td><td align="left">78</td><td align="left">2.14E−12</td><td char="." align="char">2.45</td></tr><tr><td align="left">Dendritic cells</td><td align="left">20</td><td align="left">186</td><td align="left">3.07E−12</td><td char="." align="char">1.63</td></tr><tr><td align="left">Smoking Status: Current, Former</td><td align="left">2</td><td align="left">30</td><td align="left">7.44E−12</td><td char="." align="char">4.96</td></tr><tr><td align="left">Tumor tissue vs Non tumor tissue in Current smoker vs Former Smoker</td><td align="left">2</td><td align="left">30</td><td align="left">7.44E−12</td><td char="." align="char">4.96</td></tr><tr><td align="left">Bronchoalveolar epithelium</td><td align="left">1</td><td align="left">13</td><td align="left">1.11E−11</td><td char="." align="char">15.46</td></tr><tr><td align="left">Viral response</td><td align="left">9</td><td align="left">69</td><td align="left">1.16E−11</td><td char="." align="char">2.54</td></tr><tr><td align="left">Squamous cell lung carcinoma</td><td align="left">1</td><td align="left">26</td><td align="left">2.11E−11</td><td char="." align="char">5.51</td></tr><tr><td align="left">Smoking Years Quit: &gt; 2 years</td><td align="left">1</td><td align="left">26</td><td align="left">2.11E−11</td><td char="." align="char">5.51</td></tr><tr><td align="left">Pack-years: (30–40)</td><td align="left">1</td><td align="left">26</td><td align="left">2.11E−11</td><td char="." align="char">5.51</td></tr><tr><td align="left">Metabolism</td><td align="left">7</td><td align="left">82</td><td align="left">6.06E−11</td><td char="." align="char">2.23</td></tr><tr><td align="left">Cytoprotective mechanism</td><td align="left">1</td><td align="left">70</td><td align="left">1.35E−10</td><td char="." align="char">2.38</td></tr><tr><td align="left">Mosquito-borne pathogen</td><td align="left">7</td><td align="left">63</td><td align="left">1.57E−10</td><td char="." align="char">2.52</td></tr><tr><td align="left">Zika virus associated pDCs response</td><td align="left">1</td><td align="left">28</td><td align="left">2.84E−10</td><td char="." align="char">4.55</td></tr><tr><td align="left">Zika virus</td><td align="left">8</td><td align="left">63</td><td align="left">2.84E−10</td><td char="." align="char">2.48</td></tr><tr><td align="left">SARS-COV2</td><td align="left">3</td><td align="left">19</td><td align="left">4.46E−10</td><td char="." align="char">6.81</td></tr><tr><td align="left">COVID-19</td><td align="left">3</td><td align="left">19</td><td align="left">4.46E−10</td><td char="." align="char">6.81</td></tr><tr><td align="left">Lungs tissue gene expression</td><td align="left">2</td><td align="left">27</td><td align="left">5.51E−10</td><td char="." align="char">4.57</td></tr><tr><td align="left">DE genes expressed in Obese</td><td align="left">15</td><td align="left">82</td><td align="left">7.48E−10</td><td char="." align="char">2.11</td></tr><tr><td align="left">Mucus overproduction</td><td align="left">2</td><td align="left">18</td><td align="left">8.21E−10</td><td char="." align="char">7.02</td></tr><tr><td align="left">Skeletal muscle gene expression</td><td align="left">2</td><td align="left">37</td><td align="left">1.35E−09</td><td char="." align="char">3.36</td></tr><tr><td align="left">Cell culture based smoking effect</td><td align="left">3</td><td align="left">27</td><td align="left">2.03E−09</td><td char="." align="char">4.30</td></tr><tr><td align="left">Obese vs Lean</td><td align="left">2</td><td align="left">208</td><td align="left">2.03E−09</td><td char="." align="char">1.46</td></tr><tr><td align="left">DE genes expressed in Obese, Lean</td><td align="left">3</td><td align="left">208</td><td align="left">2.06E−09</td><td char="." align="char">1.46</td></tr><tr><td align="left">SIV infection</td><td align="left">6</td><td align="left">55</td><td align="left">3.91E−09</td><td char="." align="char">2.50</td></tr><tr><td align="left">Cytokines</td><td align="left">4</td><td align="left">32</td><td align="left">4.68E−09</td><td char="." align="char">3.58</td></tr><tr><td align="left">Insulin resistance</td><td align="left">7</td><td align="left">205</td><td align="left">4.75E−09</td><td char="." align="char">1.45</td></tr><tr><td align="left">Adipose tissue gene expression</td><td align="left">3</td><td align="left">203</td><td align="left">5.36E−09</td><td char="." align="char">1.46</td></tr><tr><td align="left">Mannose metabolism</td><td align="left">1</td><td align="left">202</td><td align="left">6.76E−09</td><td char="." align="char">1.45</td></tr><tr><td align="left">Smoking Status: Current, Former, Never</td><td align="left">5</td><td align="left">41</td><td align="left">1.02E−08</td><td char="." align="char">2.90</td></tr><tr><td align="left">Early Disseminated</td><td align="left">1</td><td align="left">22</td><td align="left">2.01E−08</td><td char="." align="char">4.64</td></tr><tr><td align="left">Blood immune cells</td><td align="left">20</td><td align="left">88</td><td align="left">6.63E−08</td><td char="." align="char">1.86</td></tr><tr><td align="left">Influenza A Infection</td><td align="left">20</td><td align="left">88</td><td align="left">6.63E−08</td><td char="." align="char">1.86</td></tr><tr><td align="left">E. coli infection</td><td align="left">20</td><td align="left">88</td><td align="left">6.63E−08</td><td char="." align="char">1.86</td></tr><tr><td align="left">Staphylococcus aureus infection</td><td align="left">20</td><td align="left">88</td><td align="left">6.63E−08</td><td char="." align="char">1.86</td></tr><tr><td align="left">Streptococcus pneumoniae infection</td><td align="left">20</td><td align="left">88</td><td align="left">6.63E−08</td><td char="." align="char">1.86</td></tr><tr><td align="left">Macrophages gene expression</td><td align="left">4</td><td align="left">22</td><td align="left">8.61E−08</td><td char="." align="char">4.27</td></tr><tr><td align="left">Mitotic spindle formation genes</td><td align="left">1</td><td align="left">21</td><td align="left">8.68E−08</td><td char="." align="char">4.45</td></tr><tr><td align="left">Genotoxic</td><td align="left">2</td><td align="left">37</td><td align="left">8.68E−08</td><td char="." align="char">2.86</td></tr><tr><td align="left">Carcinogen</td><td align="left">2</td><td align="left">37</td><td align="left">8.68E−08</td><td char="." align="char">2.86</td></tr><tr><td align="left">Cell cycle</td><td align="left">4</td><td align="left">23</td><td align="left">1.30E−07</td><td char="." align="char">4.01</td></tr><tr><td align="left">Chemical induced gene expression</td><td align="left">3</td><td align="left">37</td><td align="left">1.37E−07</td><td char="." align="char">2.80</td></tr><tr><td align="left">Chemokines</td><td align="left">2</td><td align="left">16</td><td align="left">1.61E−07</td><td char="." align="char">5.65</td></tr><tr><td align="left">Dyslipemia</td><td align="left">1</td><td align="left">14</td><td align="left">1.75E−07</td><td char="." align="char">6.57</td></tr><tr><td align="left">DE genes expressed in Lean</td><td align="left">3</td><td align="left">10</td><td align="left">4.35E−07</td><td char="." align="char">9.56</td></tr><tr><td align="left">Zika virus associated mDCs response</td><td align="left">1</td><td align="left">23</td><td align="left">4.37E−07</td><td char="." align="char">3.74</td></tr><tr><td align="left">Vesicular traffic</td><td align="left">1</td><td align="left">31</td><td align="left">4.60E−07</td><td char="." align="char">2.98</td></tr><tr><td align="left">DE genes expressed in Insulin sensitive individuals</td><td align="left">1</td><td align="left">31</td><td align="left">4.60E−07</td><td char="." align="char">2.98</td></tr><tr><td align="left">Protein Metabolism</td><td align="left">2</td><td align="left">32</td><td align="left">4.60E−07</td><td char="." align="char">2.92</td></tr><tr><td align="left">Non-genotoxic</td><td align="left">1</td><td align="left">35</td><td align="left">4.60E−07</td><td char="." align="char">2.75</td></tr><tr><td align="left">Hepatocarcinogens</td><td align="left">1</td><td align="left">35</td><td align="left">4.60E−07</td><td char="." align="char">2.75</td></tr><tr><td align="left">Liver-based in vitro models</td><td align="left">1</td><td align="left">35</td><td align="left">4.60E−07</td><td char="." align="char">2.75</td></tr><tr><td align="left">Astrocytes</td><td align="left">2</td><td align="left">13</td><td align="left">7.52E−07</td><td char="." align="char">6.34</td></tr><tr><td align="left">DE genes expressed in Healthy</td><td align="left">11</td><td align="left">70</td><td align="left">9.81E−07</td><td char="." align="char">1.90</td></tr><tr><td align="left">Olive oil induced gene expression</td><td align="left">3</td><td align="left">17</td><td align="left">1.08E−06</td><td char="." align="char">4.61</td></tr><tr><td align="left">Weight associated gene expression</td><td align="left">10</td><td align="left">30</td><td align="left">1.12E−06</td><td char="." align="char">2.91</td></tr><tr><td align="left">Transport</td><td align="left">3</td><td align="left">15</td><td align="left">1.18E−06</td><td char="." align="char">5.19</td></tr><tr><td align="left">Diet intake: Olive oil</td><td align="left">2</td><td align="left">16</td><td align="left">1.19E−06</td><td char="." align="char">4.85</td></tr><tr><td align="left">Diet intake: Low calorie diet</td><td align="left">4</td><td align="left">41</td><td align="left">1.30E−06</td><td char="." align="char">2.40</td></tr><tr><td align="left">Pro-inflammatory response</td><td align="left">1</td><td align="left">12</td><td align="left">1.39E−06</td><td char="." align="char">6.58</td></tr><tr><td align="left">Regulatory T cells</td><td align="left">2</td><td align="left">26</td><td align="left">1.39E−06</td><td char="." align="char">3.17</td></tr><tr><td align="left">Immunopathology</td><td align="left">2</td><td align="left">26</td><td align="left">1.39E−06</td><td char="." align="char">3.17</td></tr><tr><td align="left">Helminth Infection</td><td align="left">2</td><td align="left">26</td><td align="left">1.39E−06</td><td char="." align="char">3.17</td></tr><tr><td align="left">Tumor tissue vs Non tumor tissue in Non-smoker vs Smoker</td><td align="left">3</td><td align="left">34</td><td align="left">1.41E−06</td><td char="." align="char">2.66</td></tr><tr><td align="left">Fusobacterium nucleatum</td><td align="left">3</td><td align="left">14</td><td align="left">1.45E−06</td><td char="." align="char">5.46</td></tr><tr><td align="left">Oral pathogen</td><td align="left">3</td><td align="left">14</td><td align="left">1.45E−06</td><td char="." align="char">5.46</td></tr><tr><td align="left">Diffuse large B-cell lymphoma</td><td align="left">1</td><td align="left">14</td><td align="left">1.54E−06</td><td char="." align="char">5.42</td></tr><tr><td align="left">Germinal center B-cell</td><td align="left">1</td><td align="left">14</td><td align="left">1.54E−06</td><td char="." align="char">5.42</td></tr><tr><td align="left">DNA repair</td><td align="left">1</td><td align="left">14</td><td align="left">1.54E−06</td><td char="." align="char">5.42</td></tr><tr><td align="left">Genomic stability</td><td align="left">1</td><td align="left">14</td><td align="left">1.54E−06</td><td char="." align="char">5.42</td></tr><tr><td align="left">Prostaglandin metabolism</td><td align="left">1</td><td align="left">10</td><td align="left">3.94E−06</td><td char="." align="char">7.39</td></tr><tr><td align="left">DE genes expressed in Low calorie diet</td><td align="left">1</td><td align="left">10</td><td align="left">3.94E−06</td><td char="." align="char">7.39</td></tr><tr><td align="left">Epithelial barrier integrity</td><td align="left">1</td><td align="left">11</td><td align="left">3.94E−06</td><td char="." align="char">6.54</td></tr><tr><td align="left">Cilia beat activity</td><td align="left">1</td><td align="left">11</td><td align="left">3.94E−06</td><td char="." align="char">6.54</td></tr><tr><td align="left">Cytoskeletal function</td><td align="left">3</td><td align="left">49</td><td align="left">4.67E−06</td><td char="." align="char">2.09</td></tr><tr><td align="left">Oxidant-related</td><td align="left">2</td><td align="left">12</td><td align="left">2.20E−05</td><td char="." align="char">5.00</td></tr><tr><td align="left">Diet intake: Dietary energy restriction</td><td align="left">3</td><td align="left">51</td><td align="left">2.20E−05</td><td char="." align="char">1.94</td></tr><tr><td align="left">Echovirus-30</td><td align="left">1</td><td align="left">18</td><td align="left">2.49E−05</td><td char="." align="char">3.44</td></tr><tr><td align="left">Blood‚ÄìCerebrospinal Fluid Barrier</td><td align="left">1</td><td align="left">18</td><td align="left">2.49E−05</td><td char="." align="char">3.44</td></tr><tr><td align="left">Polar Infection</td><td align="left">1</td><td align="left">18</td><td align="left">2.49E−05</td><td char="." align="char">3.44</td></tr><tr><td align="left">Adenocarcinoma</td><td align="left">2</td><td align="left">29</td><td align="left">3.16E−05</td><td char="." align="char">2.49</td></tr><tr><td align="left">Human papillomavirus</td><td align="left">2</td><td align="left">11</td><td align="left">4.65E−05</td><td char="." align="char">5.06</td></tr><tr><td align="left">Zika virus induced B cell response</td><td align="left">1</td><td align="left">19</td><td align="left">6.29E−05</td><td char="." align="char">3.09</td></tr><tr><td align="left">Zika virus associated B cell response</td><td align="left">1</td><td align="left">19</td><td align="left">6.29E−05</td><td char="." align="char">3.09</td></tr><tr><td align="left">Ulcerative colitis</td><td align="left">1</td><td align="left">14</td><td align="left">9.73E−05</td><td char="." align="char">3.75</td></tr><tr><td align="left">Crohn's disease</td><td align="left">1</td><td align="left">14</td><td align="left">9.73E−05</td><td char="." align="char">3.75</td></tr><tr><td align="left">Jurkat cells gene expression</td><td align="left">1</td><td align="left">14</td><td align="left">9.73E−05</td><td char="." align="char">3.75</td></tr><tr><td align="left">Viral infection</td><td align="left">19</td><td align="left">141</td><td align="left">1.10E−04</td><td char="." align="char">1.37</td></tr><tr><td align="left">T effector cells</td><td align="left">2</td><td align="left">22</td><td align="left">1.28E−04</td><td char="." align="char">2.67</td></tr><tr><td align="left">Helminth infection</td><td align="left">2</td><td align="left">22</td><td align="left">1.28E−04</td><td char="." align="char">2.67</td></tr><tr><td align="left">Before vs After diet intake</td><td align="left">7</td><td align="left">38</td><td align="left">1.45E−04</td><td char="." align="char">2.01</td></tr><tr><td align="left">Cell growth</td><td align="left">7</td><td align="left">22</td><td align="left">1.66E−04</td><td char="." align="char">2.62</td></tr><tr><td align="left">Innate Immunity</td><td align="left">5</td><td align="left">116</td><td align="left">3.50E−04</td><td char="." align="char">1.39</td></tr><tr><td align="left">Xenobiotic metabolism</td><td align="left">4</td><td align="left">27</td><td align="left">3.92E−04</td><td char="." align="char">2.22</td></tr><tr><td align="left">Bacterial infection</td><td align="left">4</td><td align="left">27</td><td align="left">4.44E−04</td><td char="." align="char">2.20</td></tr><tr><td align="left">DNA Methylation</td><td align="left">5</td><td align="left">18</td><td align="left">4.82E−04</td><td char="." align="char">2.72</td></tr><tr><td align="left">Energy restriction associated gene expression</td><td align="left">2</td><td align="left">44</td><td align="left">4.91E−04</td><td char="." align="char">1.80</td></tr><tr><td align="left">Pack-years: Above 40</td><td align="left">2</td><td align="left">10</td><td align="left">1.14E−03</td><td char="." align="char">3.75</td></tr><tr><td align="left">Gene expression induced due to fasting</td><td align="left">3</td><td align="left">11</td><td align="left">1.36E−03</td><td char="." align="char">3.40</td></tr><tr><td align="left">Diet intake: Fasting</td><td align="left">3</td><td align="left">11</td><td align="left">1.36E−03</td><td char="." align="char">3.40</td></tr><tr><td align="left">Type 2 Diabetes</td><td align="left">5</td><td align="left">19</td><td align="left">1.47E−03</td><td char="." align="char">2.38</td></tr><tr><td align="left">Maternal cigarette smoking</td><td align="left">2</td><td align="left">25</td><td align="left">2.60E−03</td><td char="." align="char">2.01</td></tr><tr><td align="left">Immune reposne</td><td align="left">2</td><td align="left">89</td><td align="left">3.69E−03</td><td char="." align="char">1.37</td></tr><tr><td align="left">Dendritic cell maturation</td><td align="left">2</td><td align="left">89</td><td align="left">3.69E−03</td><td char="." align="char">1.37</td></tr><tr><td align="left">Newcastle disease virus</td><td align="left">2</td><td align="left">89</td><td align="left">3.69E−03</td><td char="." align="char">1.37</td></tr><tr><td align="left">Cell-adhesion</td><td align="left">3</td><td align="left">28</td><td align="left">4.32E−03</td><td char="." align="char">1.85</td></tr><tr><td align="left">Diet intake vs Control</td><td align="left">17</td><td align="left">34</td><td align="left">4.93E−03</td><td char="." align="char">1.71</td></tr><tr><td align="left">Viral responses</td><td align="left">4</td><td align="left">18</td><td align="left">5.73E−03</td><td char="." align="char">2.16</td></tr><tr><td align="left">Hematopoiesis</td><td align="left">2</td><td align="left">22</td><td align="left">8.83E−03</td><td char="." align="char">1.91</td></tr><tr><td align="left">Zika virus associated CD8T cell response</td><td align="left">1</td><td align="left">13</td><td align="left">1.22E−02</td><td char="." align="char">2.31</td></tr><tr><td align="left">Calorie restriction effect on old vs young</td><td align="left">1</td><td align="left">25</td><td align="left">1.33E−02</td><td char="." align="char">1.75</td></tr><tr><td align="left">Vascularization</td><td align="left">1</td><td align="left">21</td><td align="left">1.41E−02</td><td char="." align="char">1.85</td></tr><tr><td align="left">Host susceptibility</td><td align="left">2</td><td align="left">16</td><td align="left">2.10E−02</td><td char="." align="char">1.95</td></tr><tr><td align="left">Macrophage activation</td><td align="left">2</td><td align="left">16</td><td align="left">2.10E−02</td><td char="." align="char">1.95</td></tr><tr><td align="left">Inflammatory diseases</td><td align="left">2</td><td align="left">16</td><td align="left">2.10E−02</td><td char="." align="char">1.95</td></tr><tr><td align="left">Plasma insulin level</td><td align="left">5</td><td align="left">12</td><td align="left">2.21E−02</td><td char="." align="char">2.19</td></tr><tr><td align="left">Pathogen sensing</td><td align="left">6</td><td align="left">22</td><td align="left">2.31E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Antimicrobial defense</td><td align="left">6</td><td align="left">22</td><td align="left">2.31E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Supression of T cell activation</td><td align="left">6</td><td align="left">22</td><td align="left">2.31E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Enhanced bactericidal activity</td><td align="left">6</td><td align="left">22</td><td align="left">2.31E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Inhibition of granuloma destruction</td><td align="left">6</td><td align="left">22</td><td align="left">2.31E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">HIV-1 infection</td><td align="left">9</td><td align="left">32</td><td align="left">3.48E−02</td><td char="." align="char">1.49</td></tr><tr><td align="left">Plasmodium falciparum</td><td align="left">1</td><td align="left">18</td><td align="left">3.91E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Malaria</td><td align="left">1</td><td align="left">18</td><td align="left">3.91E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Blood monocytes</td><td align="left">1</td><td align="left">18</td><td align="left">3.91E−02</td><td char="." align="char">1.72</td></tr><tr><td align="left">Hematogenous dissemination of virus</td><td align="left">6</td><td align="left">32</td><td align="left">4.04E−02</td><td char="." align="char">1.47</td></tr><tr><td align="left">Epidermal growth factor receptor/PI3K signaling pathway</td><td align="left">6</td><td align="left">32</td><td align="left">4.04E−02</td><td char="." align="char">1.47</td></tr></tbody></table></table-wrap></p>
      <sec id="Sec21">
        <title>User-defined annotations</title>
        <p id="Par36">The E.PAGE do not currently incorporate genetic data. However, to demonstrate its feasibility, we separately used two genetic datasets<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup> associated with Parkinson’s disease (PD) and developed automatic annotations using E.PAGE (Supplementary <xref rid="MOESM1" ref-type="media">SP3</xref>). An independent transcriptomic dataset associated with PD was queried<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. We uncovered annotations such as Genetic Association [Parkinson's Disease, GWAS + eQTL] and cellular response to interferon-gamma.</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec22">
    <title>Discussion</title>
    <p id="Par37">Environmental factors are known to influence the development of disease, with or without combination with genetic factors, however there is currently no curated database and enrichment tool to identify the genes and the corresponding biological processes associated with these environmental conditions. We developed E.PAGE, a database and enrichment tool to understand the gene–environment relationship. Our database was developed based on experimental evidence obtained from the published literature to establish a relationship between environmental factors, differentially expressed genes and specific biological processes associated with the genes.</p>
    <p id="Par38">To set up the database, we used <italic>cigarette smoking, infections, toxic chemicals</italic> and <italic>diet</italic>, as they constitute the primary environmental factors influencing disease outcomes<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. We made every effort to ensure completeness, accuracy and currency of the database. The current database has 237 datasets which consists of 25,789 genes in total. Traditional methods assume a linear relationship between environment and the genes<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. In our study, the annotations such as <italic>Cigarette smoking</italic> have a direct relationship with environmental variables whereas the <italic>Viral response</italic> may have direct or indirect relationship with environmental variables depending on each experiment. Thus the annotations included in the study are a combination of linear and non-linear environment variables<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. The largest number of datasets relate to <italic>diet</italic> and <italic>infections</italic> due to the long research history of these two environmental factors and disease. We manually curated each dataset using specific keywords and a brief description, abstract published with these datasets. We then developed an enrichment tool that uncovers modules associated with genes of interest using the methods we previously published<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. In six case studies, we tested E.PAGE with sets of DE genes available from the literature. Specifically, we tested two gene lists associated with autoimmunity—T1D and RA—along with those related to small cell lung cancer, COVID-19 and smoking subjects. To confirm the effect of toxic chemicals on differential gene expression, we also used gene expression data from a study on cobalt exposure.</p>
    <p id="Par39">On testing T1D and RA associated DE genes, we found a large number of gene modules related to immune responses, which supports previous studies on how malfunction in the adaptive immune response results in activation of self-reactive T cells. We also obtained a substantial number of environmental modules associated with viral and bacterial infections, which supports recent findings on how bacterial and viral infections are implicated in immune response signaling in autoimmune disease pathogenesis. The T1D and RA associated DE genes were found to be primarily enriched in <italic>infection-</italic>associated gene modules and less in gene modules associated with the environmental factors <italic>diet, cigarette smoking</italic> or <italic>toxic chemicals</italic>. This information supports the hypotheses that infection-associated immune responses are major contributors to the development of T1D and RA<sup><xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR36">36</xref></sup>. A substantial number of genes involved in the central nervous system were also related to RA, consistent with other evidence<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
    <p id="Par40">When small cell lung cancer genes were tested, we found a large number of environmental modules for DE genes to be related to <italic>lung cancer</italic>, as expected. We also found an expected link to <italic>cell cycle</italic>, since cell cycle checkpoints are disrupted leading to tumour development and cancer progression. Genes relating to <italic>cytoprotective function</italic>, <italic>mitotic spindle formation</italic> are also generally dysregulated in cancer. Recent studies that show a high incidence of retrovirus in lung small cell cancer suggest a possible direct link between infections and small cell cancer<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p>
    <p id="Par41">To further assess associations between environmental factors with toxic chemicals, we tested genes differentially expressed due to cobalt exposure against the E.PAGE database. On testing, we found the modules <italic>Genotoxicity</italic> and <italic>Carcinogen</italic> to be enriched. We also obtained a substantial number of genes differentially expressed due to toxic chemicals as environmental factors, supporting the validity of the tool to identify potential involvement of toxic chemicals on DE genes involved in critical functions in a relevant datasets.</p>
    <p id="Par42">On testing gene expression data sourced from patients with COVID-19, we found that genes differentially expressed in severe cases were linked to gene modules common between bronchoalveolar and peripheral immune environments<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. This finding shows how the E.PAGE database can be used to find commonalities between two sets of differentially expressed genes, even if they may not have many genes in common.</p>
    <p id="Par43">On testing the single-cell gene expression data for smoking we found gene modules for Cigarette smoking, Airway epithelium, Epithelial gene expression, and Chronic obstructive pulmonary disease. Additional pathways that are well known to be altered by cigarette smoking were identified. Therefore, E.PAGE was able to find relevant significantly enriched gene modules.</p>
    <p id="Par44">From the above case studies, we found that our database is highly reliable and has the potential to establish a link between environmental factors and important biological processes. In the case studies, we generally obtained a higher number of DE genes related to infection as an environmental factor. Though this link with infection may be valid, there is a possibility of dataset bias due to limited type of input data such as gene list, similarities between infection and tissue damage -associated immune responses. Additionally, our study is limited to four types of environmental variables, therefore to increase usage towards wider community more environmental datasets need to be integrated. Our study is limited to the use of MeSH terms to query GEO database for differential gene expression data. Additional statistical tests such as joint odds ratio and interaction odds ratio could be included to increase the statistical representation of the datasets<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Our study is currently limited to four types of environmental variables, therefore to increase usage in the wider community more environmental datasets will be integrated over time. Further updates will be the addition of other statistical tests to cover genetic data such as Single Nucleotide Polymorphisms, Copy Number Variants and DNA Methylations<sup><xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref></sup>.</p>
    <p id="Par45">A key benefit of this research is to predict gene–environment interactions to identify novel associations between environmental factors and disease, and to inform hypothesis synthesis and target selection. Thereby, it allows scientists and epidemiologists to dissect which genes may be influenced by environmental exposures in different disease conditions. We illustrate this by using examples from type-1 diabetes, rheumatoid arthritis, small cell lung cancer and COVID-19 datasets.</p>
    <p id="Par46">The current study lends itself to future extension to additional environmental variables such as alcohol, physical activities, life-style factors, along with inclusion of other kinds of genetic data which could facilitate the development of disease risk prediction models. Additionally, variable selection methods could be employed to select candidates for gene–environmental variables associated with the disease<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec23">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41598_2022_21988_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>These authors contributed equally: Sachin Muralidharan, Sarah Ali and Lilin Yang.</p>
    </fn>
    <fn>
      <p>These authors jointly supervised this work as senior authors: Ian H. Frazer, Ranjeny Thomas and Ahmed M. Mehdi.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary Information</title>
    <p>The online version contains supplementary material available at 10.1038/s41598-022-21988-6.</p>
  </sec>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>Concept and design of the study contributed by S.M., A.M.M., I.F., and R.T. Data collection contributed by S.M., S.A., L.Y., J.B., S.F.Z., R.A. Data analysis, and interpretation contributed by S.M., S.A., L.Y., A.M.M., J.C., I.F., S.F.Z., R.A. and R.T. Manuscript preparation contributed by S.M., A.M.M., I.F. and R.T.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Supported by NHMRC (Grant No. 1071822, 2008287, 1173927), PA Research Foundation and The Merchant Foundation. RT was supported by Arthritis Queensland and a NHMRC Senior Research Fellowship. AMM was supported by a Postdoctoral Fellowship from JDRF (3-PDF-2016-198-A-N).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>The E.PATH is freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/AhmedMehdiLab/E.PATH">https://github.com/AhmedMehdiLab/E.PATH</ext-link>.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>The R package (E.PAGE) to process E.PATH is available as an R package is openly available at <ext-link ext-link-type="uri" xlink:href="https://github.com/AhmedMehdiLab/E.PAGE">https://github.com/AhmedMehdiLab/E.PAGE</ext-link>.</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par47">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Skinner</surname>
            <given-names>MK</given-names>
          </name>
        </person-group>
        <article-title>Environmental epigenomics and disease susceptibility</article-title>
        <source>EMBO Rep.</source>
        <year>2011</year>
        <volume>12</volume>
        <issue>7</issue>
        <fpage>620</fpage>
        <lpage>622</lpage>
        <pub-id pub-id-type="doi">10.1038/embor.2011.125</pub-id>
        <?supplied-pmid 21681201?>
        <pub-id pub-id-type="pmid">21681201</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vojdani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pollard</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>AW</given-names>
          </name>
        </person-group>
        <article-title>Environmental triggers and autoimmunity</article-title>
        <source>Autoimmune Dis.</source>
        <year>2014</year>
        <volume>2014</volume>
        <fpage>798029</fpage>
        <?supplied-pmid 25610638?>
        <pub-id pub-id-type="pmid">25610638</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rappaport</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>Discovering environmental causes of disease</article-title>
        <source>J. Epidemiol. Community Health</source>
        <year>2012</year>
        <volume>66</volume>
        <issue>2</issue>
        <fpage>99</fpage>
        <lpage>102</lpage>
        <pub-id pub-id-type="doi">10.1136/jech-2011-200726</pub-id>
        <?supplied-pmid 22199396?>
        <pub-id pub-id-type="pmid">22199396</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vojdani</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>A potential link between environmental triggers and autoimmunity</article-title>
        <source>Autoimmune Dis.</source>
        <year>2014</year>
        <volume>2014</volume>
        <fpage>437231</fpage>
        <?supplied-pmid 24688790?>
        <pub-id pub-id-type="pmid">24688790</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>KY</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>MM</given-names>
          </name>
        </person-group>
        <article-title>Big data analytics for genomic medicine</article-title>
        <source>Int. J. Mol. Sci.</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>2</issue>
        <fpage>412</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms18020412</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raghupathi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Raghupathi</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Big data analytics in healthcare: Promise and potential</article-title>
        <source>Health Inf. Sci. Syst.</source>
        <year>2014</year>
        <volume>2</volume>
        <fpage>3</fpage>
        <pub-id pub-id-type="doi">10.1186/2047-2501-2-3</pub-id>
        <?supplied-pmid 25825667?>
        <pub-id pub-id-type="pmid">25825667</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ennie</surname>
            <given-names>NARK</given-names>
          </name>
        </person-group>
        <article-title>A systematic review of interventions to improve diabetes care in socially</article-title>
        <source>Diabetes Care</source>
        <year>2006</year>
        <volume>29</volume>
        <fpage>1675</fpage>
        <lpage>1688</lpage>
        <pub-id pub-id-type="doi">10.2337/dc05-1942</pub-id>
        <pub-id pub-id-type="pmid">16801602</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alberti</surname>
            <given-names>KG</given-names>
          </name>
          <name>
            <surname>Zimmet</surname>
            <given-names>PZ</given-names>
          </name>
        </person-group>
        <article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation</article-title>
        <source>Diabetes Med.</source>
        <year>1998</year>
        <volume>15</volume>
        <issue>7</issue>
        <fpage>539</fpage>
        <lpage>553</lpage>
        <pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Coletti</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Bleich</surname>
            <given-names>HL</given-names>
          </name>
        </person-group>
        <article-title>Medical subject headings used to search the biomedical literature</article-title>
        <source>J. Am. Med. Inform. Assoc.</source>
        <year>2001</year>
        <volume>8</volume>
        <issue>4</issue>
        <fpage>317</fpage>
        <lpage>323</lpage>
        <pub-id pub-id-type="doi">10.1136/jamia.2001.0080317</pub-id>
        <?supplied-pmid 11418538?>
        <pub-id pub-id-type="pmid">11418538</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Furumichi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Morishima</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>KEGG: new perspectives on genomes, pathways, diseases and drugs</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2017</year>
        <volume>45</volume>
        <issue>D1</issue>
        <fpage>D353</fpage>
        <lpage>D361</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw1092</pub-id>
        <?supplied-pmid 27899662?>
        <pub-id pub-id-type="pmid">27899662</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>QY</given-names>
          </name>
        </person-group>
        <article-title>clusterProfiler: An R package for comparing biological themes among gene clusters</article-title>
        <source>OMICS</source>
        <year>2012</year>
        <volume>16</volume>
        <issue>5</issue>
        <fpage>284</fpage>
        <lpage>287</lpage>
        <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
        <?supplied-pmid 22455463?>
        <pub-id pub-id-type="pmid">22455463</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sohani</surname>
            <given-names>ZN</given-names>
          </name>
          <name>
            <surname>Meyre</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>de Souza</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Joseph</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Gandhi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dennis</surname>
            <given-names>BB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Assessing the quality of published genetic association studies in meta-analyses: The quality of genetic studies (Q-Genie) tool</article-title>
        <source>BMC Genet.</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>50</fpage>
        <pub-id pub-id-type="doi">10.1186/s12863-015-0211-2</pub-id>
        <?supplied-pmid 25975208?>
        <pub-id pub-id-type="pmid">25975208</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>Team RC</collab>
        </person-group>
        <source>R: A Language and Environment for Statistical Computing</source>
        <year>2020</year>
        <publisher-name>R Foundation for Statistical Computing</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>Team R</collab>
        </person-group>
        <source>RStudio: Integrated Development Environment for R</source>
        <year>2021</year>
        <publisher-name>RStudio, PBC</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wickham</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Averick</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bryan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>McGowan</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>François</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Grolemund</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hayes</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Henry</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hester</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Welcome to the {tidyverse}</article-title>
        <source>J. Open Source Softw.</source>
        <year>2019</year>
        <volume>4</volume>
        <issue>43</issue>
        <fpage>1686</fpage>
        <pub-id pub-id-type="doi">10.21105/joss.01686</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Butler</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hoffman</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Smibert</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Papalexi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Satija</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2018</year>
        <volume>36</volume>
        <issue>5</issue>
        <fpage>411</fpage>
        <lpage>420</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
        <?supplied-pmid 29608179?>
        <pub-id pub-id-type="pmid">29608179</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mehdi</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Hamilton-williams</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Cristino</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ziegler</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bonifacio</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes</article-title>
        <source>JCI Insight</source>
        <year>2018</year>
        <volume>3</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1172/jci.insight.98212</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Winters</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Winters</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Amedee</surname>
            <given-names>RG</given-names>
          </name>
        </person-group>
        <article-title>Statistics: A brief overview</article-title>
        <source>Ochsner J.</source>
        <year>2010</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>213</fpage>
        <lpage>216</lpage>
        <?supplied-pmid 21603381?>
        <pub-id pub-id-type="pmid">21603381</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Drai</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Elmer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kafkafi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Golani</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Controlling the false discovery rate in behavior genetics research</article-title>
        <source>Behav. Brain Res.</source>
        <year>2001</year>
        <volume>125</volume>
        <issue>1–2</issue>
        <fpage>279</fpage>
        <lpage>284</lpage>
        <pub-id pub-id-type="doi">10.1016/S0166-4328(01)00297-2</pub-id>
        <?supplied-pmid 11682119?>
        <pub-id pub-id-type="pmid">11682119</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szumilas</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Explaining odds ratios</article-title>
        <source>J. Can. Acad. Child Adolesc. Psychiatry</source>
        <year>2010</year>
        <volume>19</volume>
        <issue>3</issue>
        <fpage>227</fpage>
        <lpage>229</lpage>
        <?supplied-pmid 20842279?>
        <pub-id pub-id-type="pmid">20842279</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaizer</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Glaser</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Chaussabel</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Banchereau</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pascual</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>PC</given-names>
          </name>
        </person-group>
        <article-title>Gene expression in peripheral blood mononuclear cells from children with diabetes</article-title>
        <source>J. Clin. Endocrinol. Metab.</source>
        <year>2007</year>
        <volume>92</volume>
        <fpage>3705</fpage>
        <lpage>3711</lpage>
        <pub-id pub-id-type="doi">10.1210/jc.2007-0979</pub-id>
        <?supplied-pmid 17595242?>
        <pub-id pub-id-type="pmid">17595242</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Identification of key genes and pathways in rheumatoid arthritis gene expression profile by bioinformatics</article-title>
        <source>Acta Reumatol. Port.</source>
        <year>2018</year>
        <volume>43</volume>
        <issue>2</issue>
        <fpage>109</fpage>
        <lpage>131</lpage>
        <?supplied-pmid 30091955?>
        <pub-id pub-id-type="pmid">30091955</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sato</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kaneda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tsuji</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Isagawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fujita</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer</article-title>
        <source>Sci. Rep.</source>
        <year>2013</year>
        <volume>3</volume>
        <fpage>1911</fpage>
        <pub-id pub-id-type="doi">10.1038/srep01911</pub-id>
        <?supplied-pmid 23714854?>
        <pub-id pub-id-type="pmid">23714854</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Permenter</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Dennis</surname>
            <given-names>WE</given-names>
          </name>
          <name>
            <surname>Sutto</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Jackson</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Stallings</surname>
            <given-names>JD</given-names>
          </name>
        </person-group>
        <article-title>Exposure to cobalt causes transcriptomic and proteomic changes in two rat liver derived cell lines</article-title>
        <source>PLoS ONE</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>1</fpage>
        <lpage>11</lpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0083751</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilk</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Rustagi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>NQ</given-names>
          </name>
          <name>
            <surname>Roque</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Martinez-Colon</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>McKechnie</surname>
            <given-names>JL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A single-cell atlas of the peripheral immune response in patients with severe COVID-19</article-title>
        <source>Nat. Med.</source>
        <year>2020</year>
        <volume>26</volume>
        <issue>7</issue>
        <fpage>1070</fpage>
        <lpage>1076</lpage>
        <pub-id pub-id-type="doi">10.1038/s41591-020-0944-y</pub-id>
        <?supplied-pmid 32514174?>
        <pub-id pub-id-type="pmid">32514174</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goldfarbmuren</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Jackson</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Sajuthi</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Dyjack</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Rios</surname>
            <given-names>CL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dissecting the cellular specificity of smoking effects and reconstructing lineages in the human airway epithelium</article-title>
        <source>Nat. Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>2485</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-16239-z</pub-id>
        <?supplied-pmid 32427931?>
        <pub-id pub-id-type="pmid">32427931</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ter Horst</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jaeger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smeekens</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Oosting</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Swertz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Host and environmental factors influencing individual human cytokine responses</article-title>
        <source>Cell</source>
        <year>2016</year>
        <volume>167</volume>
        <issue>4</issue>
        <fpage>1111</fpage>
        <lpage>24.e13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.018</pub-id>
        <?supplied-pmid 27814508?>
        <pub-id pub-id-type="pmid">27814508</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hopkinson</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Rossi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>El-Sayed Moustafa</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Laverty</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Quint</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Freidin</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Current smoking and COVID-19 risk: Results from a population symptom app in over 2.4 million people</article-title>
        <source>Thorax</source>
        <year>2021</year>
        <volume>76</volume>
        <fpage>714</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.1136/thoraxjnl-2020-216422</pub-id>
        <?supplied-pmid 33402392?>
        <pub-id pub-id-type="pmid">33402392</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19</article-title>
        <source>Nat. Med.</source>
        <year>2020</year>
        <volume>26</volume>
        <issue>6</issue>
        <fpage>842</fpage>
        <lpage>844</lpage>
        <pub-id pub-id-type="doi">10.1038/s41591-020-0901-9</pub-id>
        <?supplied-pmid 32398875?>
        <pub-id pub-id-type="pmid">32398875</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gene4PD: A comprehensive genetic database of Parkinson's disease</article-title>
        <source>Front. Neurosci.</source>
        <year>2021</year>
        <volume>15</volume>
        <fpage>679568</fpage>
        <pub-id pub-id-type="doi">10.3389/fnins.2021.679568</pub-id>
        <?supplied-pmid 33981200?>
        <pub-id pub-id-type="pmid">33981200</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pierce</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Coetzee</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes</article-title>
        <source>PLoS ONE</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>4</issue>
        <fpage>e0175882</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0175882</pub-id>
        <?supplied-pmid 28407015?>
        <pub-id pub-id-type="pmid">28407015</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kia</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Guelfi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Manzoni</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hubbard</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>RH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets</article-title>
        <source>JAMA Neurol.</source>
        <year>2021</year>
        <volume>78</volume>
        <issue>4</issue>
        <fpage>464</fpage>
        <lpage>472</lpage>
        <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.5257</pub-id>
        <?supplied-pmid 33523105?>
        <pub-id pub-id-type="pmid">33523105</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>A novel method for identifying nonlinear gene–environment interactions in case–control association studies</article-title>
        <source>Hum. Genet.</source>
        <year>2013</year>
        <volume>132</volume>
        <issue>12</issue>
        <fpage>1413</fpage>
        <lpage>1425</lpage>
        <pub-id pub-id-type="doi">10.1007/s00439-013-1350-z</pub-id>
        <?supplied-pmid 23974428?>
        <pub-id pub-id-type="pmid">23974428</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jasemi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Uras</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Erre</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Passiu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sechi</surname>
            <given-names>LA</given-names>
          </name>
        </person-group>
        <article-title>Role of infections in the pathogenesis of rheumatoid arthritis: Focus on mycobacteria</article-title>
        <source>Microorganisms</source>
        <year>2020</year>
        <volume>8</volume>
        <issue>10</issue>
        <fpage>1459</fpage>
        <pub-id pub-id-type="doi">10.3390/microorganisms8101459</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mouat</surname>
            <given-names>IC</given-names>
          </name>
          <name>
            <surname>Morse</surname>
            <given-names>ZJ</given-names>
          </name>
          <name>
            <surname>Shanina</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Horwitz</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Latent gammaherpesvirus exacerbates arthritis through modification of age-associated B cells</article-title>
        <source>Elife</source>
        <year>2021</year>
        <volume>10</volume>
        <fpage>e67024</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.67024</pub-id>
        <?supplied-pmid 34080972?>
        <pub-id pub-id-type="pmid">34080972</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pino</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Kruger</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Bortell</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The role of innate immune pathways in type 1 diabetes pathogenesis</article-title>
        <source>Curr. Opin. Endocrinol. Diabetes Obes</source>
        <year>2010</year>
        <volume>17</volume>
        <issue>2</issue>
        <fpage>126</fpage>
        <lpage>130</lpage>
        <pub-id pub-id-type="doi">10.1097/MED.0b013e3283372819</pub-id>
        <?supplied-pmid 20125005?>
        <pub-id pub-id-type="pmid">20125005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sağ</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Serdar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ibrahim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ayhan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kemal</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bilgehan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Acar</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Central nervous system involvement in rheumatoid arthritis: Possible role of chronic inflammation and tnf blocker therapy</article-title>
        <source>Acta Neurol. Belg.</source>
        <year>2017</year>
        <volume>120</volume>
        <fpage>25</fpage>
        <lpage>31</lpage>
        <pub-id pub-id-type="doi">10.1007/s13760-017-0879-3</pub-id>
        <?supplied-pmid 29288410?>
        <pub-id pub-id-type="pmid">29288410</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Robinson</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Jaing</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Pierce Campbell</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Magliocco</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Magliocco</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung</article-title>
        <source>Br. J. Cancer</source>
        <year>2016</year>
        <volume>115</volume>
        <issue>4</issue>
        <fpage>497</fpage>
        <lpage>504</lpage>
        <pub-id pub-id-type="doi">10.1038/bjc.2016.213</pub-id>
        <?supplied-pmid 27415011?>
        <pub-id pub-id-type="pmid">27415011</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simonds</surname>
            <given-names>NI</given-names>
          </name>
          <name>
            <surname>Ghazarian</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Pimentel</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Schully</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Ellison</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Gillanders</surname>
            <given-names>EM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Review of the gene–environment interaction literature in cancer: What do we know?</article-title>
        <source>Genet. Epidemiol.</source>
        <year>2016</year>
        <volume>40</volume>
        <issue>5</issue>
        <fpage>356</fpage>
        <lpage>365</lpage>
        <pub-id pub-id-type="doi">10.1002/gepi.21967</pub-id>
        <?supplied-pmid 27061572?>
        <pub-id pub-id-type="pmid">27061572</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cornelis</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Tchetgen</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chatterjee</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>FB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gene–environment interactions in genome-wide association studies: A comparative study of tests applied to empirical studies of type 2 diabetes</article-title>
        <source>Am. J. Epidemiol.</source>
        <year>2012</year>
        <volume>175</volume>
        <issue>3</issue>
        <fpage>191</fpage>
        <lpage>202</lpage>
        <pub-id pub-id-type="doi">10.1093/aje/kwr368</pub-id>
        <?supplied-pmid 22199026?>
        <pub-id pub-id-type="pmid">22199026</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thomas</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Gene–environment-wide association studies: Emerging approaches</article-title>
        <source>Nat. Rev. Genet.</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>4</issue>
        <fpage>259</fpage>
        <lpage>272</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg2764</pub-id>
        <?supplied-pmid 20212493?>
        <pub-id pub-id-type="pmid">20212493</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Winham</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Biernacka</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Gene–environment interactions in genome-wide association studies: Current approaches and new directions</article-title>
        <source>J. Child Psychol. Psychiatry</source>
        <year>2013</year>
        <volume>54</volume>
        <issue>10</issue>
        <fpage>1120</fpage>
        <lpage>1134</lpage>
        <pub-id pub-id-type="doi">10.1111/jcpp.12114</pub-id>
        <?supplied-pmid 23808649?>
        <pub-id pub-id-type="pmid">23808649</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Wong</surname>
            <given-names>KC</given-names>
          </name>
        </person-group>
        <article-title>Gene–environment interaction: A variable selection perspective</article-title>
        <source>Epistasis Methods in Molecular Biology</source>
        <year>2021</year>
        <publisher-name>Springer US</publisher-name>
        <fpage>191</fpage>
        <lpage>224</lpage>
      </element-citation>
    </ref>
  </ref-list>
</back>
